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Measures of adult shoulder function
Shoulder Pain and Disability Index (SPADI), American Shoulder and Elbow Surgeons (ASES) 
Society Standardized Shoulder Assessment Form, Constant (Murley) Score (CS), Simple 
Shoulder Test (SST), Oxford Shoulder Score (OSS), Shoulder, Disabilities of the Arm, 
Shoulder, and Hand Questionnaire (DASH) and Its Short Version (QuickDASH), University of 
California–Los Angeles (UCLA) Shoulder Rating Scale, Western Ontario Rotator Cuff (WORC) 
Index, Patient-Reported Outcomes Measurement Information System (PROMIS) Physical 
Function Upper Extremity Computerized Adaptive Test (CAT)
Buchbinder R, Ramiro S, Huang H, Gagnier J, Jia Y, Whittle S. 
Introduction
In the first systematic review of randomized controlled trials evaluating efficacy of 
interventions for painful shoulder published in 1998, none of the 31 included trials included 
a measure of function (1). Since then at least 50 instruments to measure adult shoulder 
function have been developed and used in trials for shoulder pain (2). A 2011 review of nine 
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psychometric testing had been reported, was published in a special issue of this journal 
devoted to patient outcome measures relevant to rheumatology (3). 
This updated review includes six of these nine tools and three new tools. Eight were chosen 
on the basis of being the most commonly used in randomized controlled trials in the last five 
years identified searching Ovid MEDLINE and Ovid EMBASE from 2015 until 9 December 
2019, using search strategies developed by Cochrane Musculoskeletal to identify common 
shoulder disorders, combined with Cochrane's highly sensitive search strategies for 
randomized controlled trials. We also included Patient-Reported Outcomes Measurement 
Information System (PROMIS) (Physical Function  Upper Extremity Computerized Adaptive 
Tests (CATs). Studies evaluating the measurement properties of the nine tools in shoulder 
conditions were identified by combining the relevant tool and search terms for common 
shoulder disorders with a search filter developed by Terwee et al for identifying such studies 
(4). 
There have been many psychometric studies of our chosen measures of adult shoulder 
function since the 2011 review. Many of the tools have been cross-culturally adapted into  
multiple languages and these studies also provide important information regarding 
psychometric properties. Our review summarises the available information about how these 
measures perform for different patient populations in different settings.
SPADI - Shoulder Pain and Disability Index
Description
Purpose. Patient-reported outcome measure (PROM) of shoulder pain and function. The 
original version was published in 1991 and developed as a joint-specific measure for any 
disorders of the shoulder joint for use in an outpatient setting (5). It was developed by a 
panel of rheumatologists and a physical therapist. It initially comprised 20 items that the 
panel considered to be measures of shoulder pain and function; seven items were 
subsequently removed due to inadequate test-retest reliability or poor correlation with 
shoulder range of motion, resulting in a 13-item scale.
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Number of items. 13 items in total, 5 in pain subscale and 8 in disability subscale.
Response options/scale. All items were originally rated using a visual analogue scale (VAS) 
(5). More recent versions have most commonly used an 11-point (0–10) numerical rating 
scale (NRS) (6). Anchors for each of the pain items are 0 = ‘no pain’ and 10 = ‘worst pain 
imaginable’, and for the 8 disability items are 0 = ‘no difficulty’ and 10 = ‘so difficult it 
requires help’.
Recall period for items. One week
Cost to use. Free of charge. 
How to obtain. Printed in various references, e.g., (7). Free PDF version online at 
https://www.tac.vic.gov.au/files-to-move/media/upload/spi.pdf, or as an online calculator 
at https://www.orthotoolkit.com/spadi/.
Practical application
Method of administration. Self-assessment, either using pen and paper or electronic 
version. May also be administered via telephone (8).
Scoring. Each item scored 0 (best) to 10 (worst). A minimum of 2/3 of questions must be 
answered in each subscale in order to calculate a score. The subscore is the sum of scored 
items divided by the maximum possible score x 100%. The total SPADI score is the 
unweighted mean of the pain and disability subscales.
Score interpretation. Possible scores range from 0 (best) to 100 (worst). There are no cutoff 
points to indicate severity. Normative data are available from a sample of 635 healthy 
volunteers in Australia (n=323) and Canada (n=312) (9). Subjects were included if they had 
no diagnosed shoulder pathology in the dominant arm and had no active shoulder 
pathology or shoulder surgery in the previous three years. Participants without a history of 
shoulder problems had a lower (better) mean score (3.3 on a 0-100 scale) than those who 
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had a higher (worse) mean score (4.2) than men (2.7) after adjustment for nationality 
(p=0.026) and scores increased with age.
Respondent time to complete. Median time to complete 2 minutes (range 1–4 minutes) 
(10).
Administrative burden. Scoring is straightforward and no special software or equipment is 
required. Some electronic tools include automated calculation of final score. Administration 
and scoring takes 5 minutes (5).
Translations/adaptations. Translated into multiple languages. Cross-cultural validation has 
been performed for the following languages: Spanish (11), Chinese (12), Arabic (13), Danish 
(14), Norwegian (15), Dutch (16), Indian (Tamil (17), Hindi (18), Greek (19), Turkish (20), 
Brazilian Portuguese (21), Persian (22), Thai (23), Nepali (24), Italian (25) and German (26).
Psychometric information
Floor and ceiling effects. No floor or ceiling effects have been found in patients with rotator 
cuff disease (27), or after shoulder arthroplasty (28).
Reliability. There is evidence for high internal consistency, with high Cronbach’s alpha 
scores for the total SPADI scale and the individual subscales in various settings, including 
shoulder disorders in outpatients (Cronbach’s alpha: total = 0.96, disability = 0.95, pain = 
0.89) (29); population-based individuals with shoulder pain (Cronbach’s alpha: SPADI = 0.92, 
disability = 0.90, pain = 0.85)(8); and Spanish patients with shoulder pain/dysfunction after 
surgery for breast cancer: Cronbach’s α = 0.965 (30).
Test-retest reliability was moderate in the original development study (Intraclass 
Correlation Coefficient (ICC): 0.66, 95% CI 0.42 to 0.81), although only 37 subjects with 
shoulder pain were included (5). Higher ICCs have been reported in subsequent studies in 
various populations, including patients with general shoulder pain (ICC = 0.91)(31); adhesive 
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disability subscale 0.86 (95% CI 0.78 to 0.92)(32); and Spanish patients with shoulder 
pain/dysfunction after surgery for breast cancer (ICC = 0.992)(30). 
Validity. Analysis of structural validity suggests that the English SPADI consists of two 
factors (pain and disability), which load approximately onto the two subscales. Although 
factor analyses in the development paper (5) and in a large RCT of subjects with full-
thickness rotator cuff tears (33) produced two factors that did not map onto the subscales 
with complete fidelity, other factor analyses in a larger populations of community-dwelling 
individuals with shoulder pain have demonstrated more distinct loading of pain and 
disability items onto separate factors, suggesting that the SPADI is indeed bidimensional (7, 
8).
A Rasch model analysis of 1030 patients referred for physiotherapy for shoulder pain also 
demonstrated a bidimensional structure, however there was evidence of differential item 
functioning for some items in the disability subscale (e.g., washing hair and putting on a 
shirt were more difficult for women than men, and putting on trousers was more difficult 
for people aged 60 or older). This suggests greater structural validity for the pain subscale 
than the disability subscale, and implies that the two subscales should be reported 
separately (34).
There is evidence for moderate to high correlation between SPADI scores and other generic 
and shoulder-specific pain and disability measures. This has been demonstrated for general 
shoulder disorders and specific conditions including rotator cuff disease and adhesive 
capsulitis, in various settings including primary care, hospital outpatients and the general 
community. Pearson’s or Spearmans’ correlations to other instruments or measures, and 
the population it has been measured in are as follows:
Shoulder range of motion: Patients with shoulder pain: r = 0.55 to  0.80 (5).
Disabilities of Arm, Shoulder and Hand (DASH): Following shoulder arthroplasty: r = 0.93 
(28); and participants in two clinical trials of treatments for adhesive capsulitis: r = 0.55 (35). 
American Shoulder and Elbow Surgeons (ASES) Shoulder Score (ASES): following shoulder 
arthroplasty r = 0.81 (28); and patients referred to an upper extremity clinic for shoulder 
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Simple Shoulder Test (SST): Patients referred to an upper extremity clinic for shoulder 
problems: r = 0.74 (36). 
Constant Murley (CM) Shoulder scale: Following shoulder arthroplasty: r = 0.82 (28); 
degenerative or inflammatory shoulder disease referred for surgery: r = 0.53 (37); and 
patients enrolled in physical therapy for shoulder dysfunction: r = 0.56 (38).  
Oxford Shoulder Score (OSS): Patients attending a specialist shoulder clinic with subacromial 
impingement): r = 0.85 (39); degenerative or inflammatory shoulder disease referred for 
surgery: r = 0.74 (37); shoulder problems in Turkish patients: Cronbach’s r = -0.74 (and r = -
0.71 and -0.72 for the pain and disability subscales respectively) (40)
Shoulder Disability Questionnaire (SDQ): Patients with shoulder pain in primary care: r = 
0.57 (10).  
Shoulder Rating Questionnaire (SRQ): Patients with shoulder pain in primary care: r = 0.83 
(10).  
Sickness Impact Profile (SIP): Patients with shoulder pain in outpatient physiotherapy clinic: 
r = 0.57 (41); and community volunteers with shoulder pain: r = 0.45 (42). 
Short-Form 36 (SF-36) Physical Component Scale: patients with shoulder pain in the general 
community: r = -0.46 (8). 
Health Assessment Questionnaire (HAQ): Participants in two clinical trials of treatments for 
adhesive capsulitis: r = 0.55 (35). 
Responsiveness. The total SPADI score exhibits good responsiveness as measured by Area 
Under the Curve (AUC) of the Receiver Operating Characteristic (ROC) curve. AUC was 0.87 
(95% CI 0.79 to 0.95) in subjects in primary care receiving non-surgical treatments for 
shoulder pain (10), ranged from 0.81 (95% CI 0.78 to 0.84) to 0.85 (95% CI 0.82 to 0.88) in 
subjects receiving physical therapy for shoulder pain (43), and from 0.74 (95% CI 0.64 to 
0.83) to 0.85 (95% CI 0.76 to 0.93) in clinical trials of interventions for adhesive capsulitis 
(35). 
The SPADI has also been found to have greater or at least comparable responsiveness 
compared with other shoulder-specific measures. Reported Effect Sizes (ES) and 
Standardized Response Means (SRMs) of the SPADI total score and subscales in  various 
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Total shoulder arthroplasty: SPADI: ES = 2.10, SRM = 1.72; SPADI pain: ES = 2.12, SRM = 1.71, 
SPADI function: ES = 1.77, SRM = 1.51 (44). This was better than the DASH (ES = 1.19) and 
comparable to the  ASES (ES = 2.13). 
Adhesive capsulitis, trials of oral steroids and hydrodilatation: ES = 1.20 to 1.64, SRM = 1.27 
to 1.68, and greater responsiveness of the SPADI was observed compared with the Croft 
Index (ES = 0.87 to 1.21) or DASH (ES = 0.55 to 0.83) (35).
Shoulder pain, physical therapy: ES = 1.26, SRM = 1.38 (41); and ES = 1.26, 1.71, SRM = 1.35,  
1.75 at 6-week and 6-months respectively and similar to the QuickDASH (ES = 1.04, 1.40, 
SRM = 1.26, 1.56 at 6-week and 6-months respectively)(43). 
Rotator cuff surgery or total shoulder arthroplasty: SRM = 1.23 (31). This was better than 
the SRQ (SRM = 0.65) and comparable to the SST (SRM = 1.05).
Various upper extremity disorders, occupational or physical therapy: ES 1.21, SRM 1.08, 
which was similar to the DASH (ES 1.06, SRM 1.08) and SF-36 Physical Component Summary 
(PCS) scale (ES 1.20, SRM 1.07) (45).
Spanish patients with shoulder pain/dysfunction after surgery for breast cancer: ES: 0.59, 
SRM = 0.82 (30).
Minimally important differences. Minimal detectable change (MDC) for the SPADI total 
score has been estimated to be 18.1 points (musculoskeletal upper extremity problems) 
(45); and 17 to 19.7 points (Norwegian SPADI in patients receiving treatment for adhesive 
capsulitis and rotator cuff disease, respectively) (15, 32).
The Minimally Clinically Important Difference (MCID) has been estimated to be 13.2 points 
(musculoskeletal upper extremity problems) (45); 20 points (Norwegian SPADI in patients 
receiving non-surgical treatment for rotator cuff disease) (27); and 8 to 10 points (shoulder 
pain presenting to primary care) (6, 10). Variation in the estimated MCIDs is likely to reflect 
differences in methodology and populations, however it is possible that in some situations 
the MCID may be smaller than the MDC. It has been suggested that a change of 
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Generalizability. The SPADI is a shoulder-specific measure and has been used in populations 
with various shoulder disorders, primarily non-specific shoulder pain or rotator cuff 
disorders, but also in adhesive capsulitis and after shoulder arthroplasty.
Use in clinical trials. The SPADI had been used in almost 50 randomised controlled trials of 
interventions for various shoulder disorders up to the end of 2015 (2). Recent examples 
include trials of therapeutic deep heat for shoulder pain (46), exercise versus physiotherapy 
for rotator cuff disease (47), cervicothoracic manual therapy (48), glucocorticoid injections 
for shoulder pain (49), intra-articular hyaluronate and tramadol injections for adhesive 
capsulitis (50), and extracorporeal shockwave therapy for shoulder pain (51). In some cases 
in which the SPADI was used as an outcome measure for trials performed in countries 
where English is not the primary language, validated translations were used (51) but in 
many cases it was unclear whether this was the case (46, 50).
Critical appraisal of overall value to the rheumatology community
Strengths. The SPADI is brief, easy to administer and score, has good overall evidence for 
construct validity and responsiveness, and has been used and tested in numerous settings. 
It is readily obtained at no cost, and cross-cultural validation has been performed for several 
languages.
Caveats and cautions. Factor analysis and Rasch modelling suggest that the SPADI should be 
treated as separate subscales, however there may not be clear demarcation between 
underlying concepts in the two scales, and the disability subscale may not provide true 
interval-level measurement (33, 34). The upper anchor label for the disability subscale (‘so 
difficult it requires help’) is potentially ambiguous as the perceived requirement for help 
may vary according to the level of help available to the individual respondent. The MCID 
may be smaller than the MDC, therefore a change of at least the MDC (17-20 points) is 
required to be confident of a clinically-important change. 
Clinical usability. Useful in a clinical context for assessing both joint-specific pain and 
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Research usability. Brief, easy to administer, responsive. Valid for intervention and 
population-level studies. 
American Shoulder and Elbow Surgeons (ASES) Society Standardized Shoulder Assessment 
Form
Description
Purpose. The ASES Shoulder Assessment form was developed to be a baseline measure of 
shoulder function applicable to all patients regardless of diagnosis (52). The requirements 
were that it should be easy to use, assess activities of daily living (ADL) and include a patient 
self-evaluation section. A draft version was developed based upon a review of all relevant 
forms that existed at the time, and modified based upon two rounds of feedback from the 
ASES Society’s membership. In 1998, the original ASES was modified to the modified ASES 
(mASES) by deleting two ADL items (sleep on painful side and throw ball overhead) and 
adding five new ADL items (open a jar of food, cut with a knife, use a phone, do up buttons 
and carry shopping bag) to make a whole extremity questionnaire (31). This version does 
not appear to be used for shoulder conditions. 
Content or domains. The patient self-assessment section comprises three domains: pain, 
ADLs and instability. The physician assessment comprises four domains: range of motion, 
signs, strength and instability. Most commonly however only the two domains of patient 
self-assessment of pain and ADLs is used. 
Number of items. The full ASES comprises 18 patient self-evaluation items (6 pain, 10 ADLs, 
2 instability) and 29 physician-assessed items (5 range of motion, 11 signs, 5 strength, 8 
instability). There is also one item asking the patient to indicate where the pain is on a 
diagram and one open item asking the physician about physical findings. Most commonly 
only the 16 items evaluating patient-reported assessment of pain and ADLs is used.
Response options/scale. Pain. For four items (Are you having pain in your shoulder?; do you 
have pain in your shoulder at night?; do you take pain medication (aspirin, Advil, Tylenol 
etc.)?; and do you take narcotic pain medication (codeine or stronger)?) the response 
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(average) and one item is a 0-10 pain VAS (how bad is your pain today?) with anchors of  0 - 
no pain at all to 10 – pain as bad as it can be. If there is pain in the shoulder then the 
respondent marks the site on the front and back of a diagram. 
ADLs. Response options for all ten items (Put on a coat; Sleep on your painful affected side; 
wash back/do up bra in back; manage toileting; comb hair; reach a high shelf; lift 10 lbs 
above shoulder; throw a ball overhand; do usual work; do usual sport) are 4-point ordinal 
Likert scales:0 - unable to do, 1 - very difficult, 2 - somewhat difficult, and 3 - not difficult). 
For the last two items (do usual work, do usual sport) the respondent is asked to list what 
these are.
Instability. For one item (Does your shoulder feel unstable (as if it is going to dislocate?)) the 
response option is yes/no and the other item is a 0-10 VAS (how unstable is your shoulder?) 
with anchors of 0 – very stable at all to 10 – very unstable.
Physician-assessed range of motion. Preferably using a goniometer the physician measures 
both active and passive motion in forward elevation (maximum arm-trunk angle), external 
rotation (arm comfortably at side), external rotation (arm at 90° abduction), internal 
rotation (highest posterior anatomy reached with thumb) and cross-body abduction 
(antecubital fossa to opposite acromion). 
Physician-assessed signs. Four items (supraspinatus/greater tuberosity tenderness; AC joint 
tenderness; biceps tendon tenderness (or rupture); and other tenderness (list)) have 0 to 3 
Likert scale responses (0 none, 1 -mild, 2- moderate, 3 -severe). The other seven items 
(impingement I; impingement II; impingement III; subacromial crepitus; scars, atrophy and 
deformity) are all yes/no responses. If scars or atrophy is present, the respondent is asked 
to indicate the location and if deformity is present the respondent is asked to describe it. 
Physician-assessed strength. For one item (testing affected by pain) the response option is 
yes/no. The remaining four items (forward flexion, abduction, external rotation, internal 
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movement with gravity eliminated, 3 - movement against gravity, 4 - movement against 
some resistance, 5 – normal power). 
Physician-assessed instability. For four items (anterior translation; posterior translation; 
interior translation (sulcus sign) and anterior apprehension) the response options for 
instability are graded as 0 - if absent, 1 - if mild (0 to 1 cm translation), 2 - if moderate (1 to 2 
cm translation or translates to the glenoid rim), 3 - if severe (greater than 2 cm translation 
or over rim of glenoid). Four items (reproduces symptoms, voluntary instability, relocation 
test positive, generalized laxity) the response options are yes/no. The final item asks if there 
are any other physical signs with an open field.
 
Recall period for items. Patient-reported outcomes – not stated except for some items 
when the recall period is ‘today’. 
Cost to use. Free of charge.
How to obtain. Printed in the original reference (52). The patient self-report section can be 






Method of administration. Both patient self-assessment and physician-assessment for the 
full ASES but most commonly only the self-assessment component assessing pain and ADLs 
is used. The remaining information applies to this abbreviated version of the ASES.
Scoring. The ASES score is comprised of only the patient self-evaluation of pain and ADLs 
with equal weight given to degree of pain experienced by the patient (50 points) and the 
cumulative ADL score (50 points). The pain score is reversed (by subtracting the score from 
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30  and multiplied by 5/3. The formula is: [(10 – VAS pain score)  x 5] +  [5/3 x cumulative 
ADL score]. This derives a score out of a possible 0 – 100. Some studies also report separate 
ASES pain and function (ADL) subscale scores. The instability items, remaining five pain 
items and the physician assessment are not included in the ASES score. However one study 
has devised a scoring method for physician assessment (28). 
Score interpretation. A higher ASES score indicates better pain and disability (0 - worst to 
100 – best). A missing rule or distinct cut-offs to reflect severity have not been published. 
Normative data are available based upon a sample of 343 patients (aged 6 to 87 years) from 
an outpatient orthopaedic center being seen for conditions unrelated to the shoulder 
(patients with prior shoulder problems also excluded)(53). Overall, the mean (SD) ASES 
score was 92.2 (14.5) points and the score decreased with age. Those aged 60 years and 
above had decreased ability to lift above shoulder level and reach behind the back when 
compared with younger cohorts. 
Normative data are also available in 635 asymptomatic, healthy volunteers in Australia 
(N=323) and Canada (N=312)(9). Participants were excluded if they had a history of active 
shoulder pathology or a history of recent surgery (within the last three years) or joint 
arthroplasty. People without a history of shoulder pathology reported a higher (better) 
mean ASES compared to those with a history of a shoulder problem (96.7 (range 0-100) 
versus 93.0, Wilcoxon rank sum test p=0.0003). No differences in scores were observed in 
people with and without current wrist or elbow problem or handedness. Women had 
slightly lower scores (95 versus 97 in men, p=0.03) and scores declined with increasing age. 
Respondent time to complete. Less than 5 minutes (52, 54). All items are easy to read and 
understand and are not suggestive or emotionally sensitive. Missing data are very rare. 
Administrative burden. The patient section can be administered without the clinical section 















This article is protected by copyright. All rights reserved
Translations/adaptations. Translated into multiple languages. Cross-cultural validation has 
been performed in German (55), Italian (56), Brazilian Portuguese (57, 58), Spanish (59), 
Finnish (60), Turkish (61) and Tunisian Arabic (62). 
Psychometric Information
Floor and ceiling effects. Many studies have reported acceptable floor and ceiling effects 
across different patient populations including: planned surgery for rotator cuff disease or 
glenohumeral arthritis (0% floor and ceiling), instability (0% floor, 1.3% ceiling) (63); 
following shoulder arthroplasty (1% floor, 8% ceiling) (28, 55); impingement, adhesive 
capsulitis or glenohumeral arthritis (0% floor and ceiling) (56); rotator cuff disease (2.3% 
floor and ceiling) (64); and rotator cuff repair, arthroplasty or physical therapy for 
impingement or adhesive capsulitis (<4% floor and ceiling) (65). One study in people with 
impingement reported ASES function subscale floor and ceiling effects of 5% and 22.4% 
respectively (66). 
Reliability. Internal consistency of the ASES has been found to range from Cronbach’s  0.61 �
to 0.96 across various study populations with different shoulder condition including in 
mixed population referred for physical therapy including some post-surgery: 0.86 (67); 
mixed population with impingement, adhesive capsulitis and glenohumeral arthritis: 0.85 
(56); instability: 0.61, rotator cuff disease: 0.64 and glenohumeral arthritis 0.62 (63); post 
shoulder arthroplasty 0.96 (55); various shoulder conditions, non-surgical: 0.89 to 0.92, 
post-surgery: 0.91 (68); mixed outpatient population: 0.88 (61); rotator cuff disease 
including tears or adhesive capsulitis: 0.813 (62); rotator cuff disease, glenohumeral or 
acromioclavicular arthritis and instability: 0.88 (95% Cl 0.84 to 0.91) (60); and mixed 
population mainly rotator cuff tears: 0.91 (59); shoulder dysfunction: 0.794 (58). One study 
including people with rotator cuff disease, superior labral anterior posterior (SLAP) lesions 
and instability following surgery reported acceptable internal consistency for the pain 
(0.711) and ADL (0.850) subscales (69). 
Good to excellent test-retest reliability is reported across many studies involving various 
study populations with differing shoulder conditions. These include mixed population 
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0.91)(67); various shoulder conditions (non-surgical: ICC = 0.84 (95% CI 0.66 to 0.92), post-
surgery: ICC = 0.91, 95% CI0.82–0.96)(68); impingement, adhesive capsulitis and 
glenohumeral arthritis (ICC = 0.91) (56); rotator cuff disease, instability and glenohumeral 
arthritis (ICC = 0.94, 95% CI 0.88 to 0.97)(63); post shoulder arthroplasty (ICC = 0.93, 95% CI 
0.90-0.95)(55); rotator cuff disease including tears or adhesive capsulitis (ICC = 0.96, 95% CI 
0.918 to 0.981) (62); mixed outpatient population (ICC = 0.94 (0.95 and 0.86 for pain and 
ADL subscales respectively) (61); rotator cuff disease, glenohumeral or acromioclavicular 
arthritis and instability (ICC = 0.83, 95% CI 0.70 to 0.90) (60); rotator cuff repair, arthroplasty 
or physical therapy impingement or adhesive capsulitis (CC = 0.82) (65); shoulder 
dysfunction (CC = 0.75) (58); and no shoulder pain (ICC = 0.96)(53).
One study reported excellent item reliability (whether patients with similar shoulder 
function answer the questions similarly, Pearson’s correlation coefficient = 0.98) and 
moderate person reliability (how precisely a test discriminates between patients of different 
abilities or reliably ranks respondents, Pearson’s correlation coefficient 0.48) (64). One 
study of patients with impingement reported good person reliability 0.86 (66), while one in 
patients with rotator cuff disease reported person reliability to be fair (0.48), and inferior to 
the SST (0.71, moderate) and PROMIS PF CAT (0.93, excellent)(64).
Validity. One study has examined the Spanish version of the pASES using both confirmatory 
factor and Rasch analysis (59). Factor loadings for confirmatory factor analysis were >0.40 
and the Rasch model confirmed the unidimensionality of the scale, although ADL item 10 
(do usual sport) was suggested to be uninformative. Another study found that the ASES is 
likely not unidimensional with 27.9%  unexplained variance, consistent with its inclusion of 
both pain and function items (64). This compared with unexplained variance of only 4.5% 
for the PROMIS PF CAT and 8.4% for the SST. While the SST also includes pain and function 
item, only 2 out of 12 questions relate to pain in contrast to contributing 50% of the ASES 
final score. 
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SPADI: patients post arthroplasty 0.81 (28), 0.92 (55) and post total –0.942 and reverse –
0.932 hemiarthroplasty (70); mixed outpatient population: 0.82 (61);
Western Ontario Rotator Cuff Index (WORC): patients who were receiving physical therapy 
for impingement or after rotator cuff repair, acromioplasty or decompression surgery: 0.81 
(71)
Western Ontario Stability Index (WOSI): mixed population with rotator cuff disease, isolated 
superior labral anterior posterior (SLAP) lesions, and shoulder instability after surgery: 0.15 
(69)
Rowe, rating sheet for Bankart repair score: mixed population with rotator cuff disease, 
isolated superior labral anterior posterior (SLAP) lesions, and shoulder instability after 
surgery: 0.15 (69)
DASH: patients post arthroplasty 0.79 (28), 0.84 (55);  patients with impingement, adhesive 
capsulitis and glenohumeral arthritis: 0.92 (56); shoulder dysfunction: 0.69 (58)
CM Scale: patients post arthroplasty 0.71 (28); mixed population with rotator cuff disease, 
isolated superior labral anterior posterior (SLAP) lesions, and shoulder instability after 
surgery 0.36(69); mixed population, the majority with rotator cuff tears: 0.62 (59); rotator 
cuff tears: 0.871(72) 
SST: mixed population with rotator cuff disease, isolated superior labral anterior posterior 
(SLAP) lesions, and shoulder instability after surgery 0.35(69); mixed outpatient population 
including  rotator cuff disease, glenohumeral or acromioclavicular arthritis and instability: 
0.73 (60); rotator cuff disease: 0.536 (64); post total –0.89 and reverse –0.87 
hemiarthroplasty (70)
UCLA: mixed population with rotator cuff disease, isolated superior labral anterior posterior 
(SLAP) lesions, and shoulder instability after surgery 0.38(69); arthroscopic rotator cuff 
population, pre-, 6, 12 and 24 months post-surgery): Very high correlation overall (r =  0.91, 
P <  .001); moderate in the preoperative period (r =  0.67, P <  .001); high at 6 months after 
surgery (r =  0.87, P <  .001) and very high at 12 and 24 months (r =  0.90 and 0.92, P <  
.001)(73)
Rotator Cuff QOL: patients who were receiving physical therapy for impingement or after 
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Single Assessment (or Alpha) Numerical Evaluation (SANE) score: Following rotator cuff 
repair: 0.75,  revision: 0.88, SLAP repair: 0.78, overall: 0.8 (74); rotator cuff repair: 0.85, total 
shoulder replacement: 0.72; physical therapy: 0.82 (65)
Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function
Computerized Adaptive Test (PF CAT): rotator cuff disease: 0.581 (64); planned surgery for 
rotator cuff tear: 0.43(75); impingement: 0.694, ASES function subscale: 0.664 and pain 
subscale: 0.426 (66)
Patient-Reported Outcome Measurement Information System Physical Function Upper 
Extremity Computer Adaptive Testing (PROMIS PFUE CAT): shoulder pain (excluding patients 
with prior rotator cuff surgery, shoulder surgery in last 6 months or partial rotator cuff tear): 
0.72 (76); planned surgery for rotator cuff tear: 0.59(75)
Patient-Reported Outcome Measurement Information System Pain Interference Computer 
Adaptive Testing (PROMIS PI CAT): planned surgery for rotator cuff tear: -0.43(75); 
impingement: 0.729, ASES function subscale: 0.667 and pain subscale: 0.594 (66)
SF-36 bodily pain: patients with impingement, adhesive capsulitis and glenohumeral 
arthritis: 0.60 (56) and patients post arthroplasty: 0.65 (55); mixed population: 0.64 (61); 
shoulder dysfunction: 0.60 (58); mixed population with rotator cuff disease, isolated 
superior labral anterior posterior (SLAP) lesions, and shoulder instability after surgery 0.05 
(69); mixed outpatient population including  rotator cuff disease, glenohumeral or 
acromioclavicular arthritis and instability: 0.68 (60); mixed population, the majority with 
rotator cuff tears: 0.74 (59)
SF-36 PCS: patients post arthroplasty 0.64 (28, 55); patients with impingement, adhesive 
capsulitis and glenohumeral arthritis: 0.48 (56); mixed population referred for physical 
therapy including some after surgery: 0.40 (67); mixed population with rotator cuff disease, 
isolated superior labral anterior posterior (SLAP) lesions, and shoulder instability after 
surgery 0.20 (69); mixed outpatient population including  rotator cuff disease, glenohumeral 
or acromioclavicular arthritis and instability: 0.57 (60); mixed population, the majority with 
rotator cuff tears: 0.65 (59)
SF-36 physical functioning: patients with impingement, adhesive capsulitis and 
glenohumeral arthritis: 0.47 (56); patients post arthroplasty 0.57 (55); mixed population 
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(61); shoulder dysfunction: 0.50 (58); mixed population with rotator cuff disease, isolated 
superior labral anterior posterior (SLAP) lesions, and shoulder instability after surgery 0.27 
(69); mixed outpatient population including  rotator cuff disease, glenohumeral or 
acromioclavicular arthritis and instability: 0.51 (60); mixed population, the majority with 
rotator cuff tears: 0.59 (59)
Clinician assessed component of the ASES: patients post arthroplasty 0.48 (28)  
Spearman’s correlation coefficients of the ASES scale to other instruments in a population 
with no current shoulder pathology were as follows: modified UCLA r = 0.65; CM: r = 0.48; 
OSS: r = 0.71; SPADI r = -0.78; and Stanmore Percentage of Normal Shoulder Assessment 
(SPONSA): r = -0.61 (9).
Responsiveness. The ASES has been found to have good or at least comparable 
responsiveness compared with other shoulder-specific measures. Reported ES and SRM in  
various shoulder conditions and settings are as follows:
Shoulder arthroplasty (rheumatoid or osteoarthritis): ES = 2.13, SRM = 1.81 (44)
Mixed population, the majority with rotator cuff tears followed to 6 months post treatment: 
Standardised ES = 0.80, SRM = 0.75 (ES greater among those who received surgery versus 
other treatments) (59) 
Calcific tendinitis: subacromial steroid: ES = 1.65 to 1.84 (77)
Mixed population referred for physical therapy including some after surgery: ES = 1.39, SRM 
= 1.54 (67)
Impingement or after rotator cuff repair, acromioplasty or decompression surgery: SRM = 
1.42 (71) 
Rotator cuff disease: SRM 1.16, instability: SRM 0.93, glenohumeral arthritis: SRM = 1.11 
(63)
Rotator cuff disease, isolated superior labral anterior posterior (SLAP) lesions and shoulder 
instability after surgery: ES = 0.617, SMR = 0.771  (69)
Minimally important differences. An MDC of 9.4 points (90%CI 15.5) has been reported in 
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The MCID of the ASES has been reported to range from 6.3 to 26.9 points depending upon 
study population and method of ascertainment as follows: 
Mixed population referred for physical therapy including some after surgery: 6.4 points (67)
Tendinitis or rotator cuff tear treated with nonoperative modalities: ASES function subscale: 
12.01 points, pain subscale: 16.92 points (78)
Post arthroplasty (total, reverse or hemi): 20.9 points (79)
Post arthroplasty (total or reverse): 6.3 (95% CI 2.3 to 15.0) to 13.5 (95% CI 4.8 to 22.3) 
points depending upon the anchor (80); 6.5 points for ASES function subscale and 8 points 
for ASES pain subscale (81)
Rotator cuff repair: 11.1 points (82)
Full thickness rotator cuff tears: 21.9 points (anchor-based) and 26.9 points (distribution 
based) (83)
Generalizability. The patient self-reported component of the ASES has been used widely to 
assess outcome from different surgical and non-operative treatments in people with varying 
shoulder conditions including glenohumeral arthritis, rotator cuff disease, shoulder 
instability and adhesive capsulitis.  
Use in clinical trials. The ASES had been used in 43 randomised clinical trials up to the end 
of 2015 (2). It remains extremely popular and has been used in at least 35 trials in the last 
five years including double versus single row rotator cuff repair (84); steroid injection versus 
arthroscopic capsular release for early stage adhesive capsulitis (85); rotator cuff repair with 
and without distal clavicle resection (86-88); relaxation exercises to reduce postoperative 
pain after rotator cuff repair (89); subacromial autologous conditioned plasma versus 
glucocorticoid for symptomatic partial rotator cuff tears (90); subacromial autologous 
platelet-rich plasma versus glucocorticoid for symptomatic partial rotator cuff tears (91); 
135 versus 155 degrees reverse arthroplasty prosthesis for rotator cuff arthropathy (92); 
liposomal bupivacaine vs. continuous peripheral nerve block following arthroplasty (93); 
glucocorticoid injection versus oral NSAIDs for adhesive capsulitis (94); 
12-month exercise program versus usual are after rotator cuff repair (95); multimodal 
analgesia injection combined with glucocorticoid versus saline injection after arthroscopic 
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tenodesis (97); optimum versus maximum tension bridging suture for rotator cuff repair 
(98); platelet-rich plasma after rotator cuff repair (99); arthroscopic versus open 
stabilization for anterior shoulder subluxation (100); high versus low dose intraarticular 
glucocorticoid for shoulder stiffness (101); triple-loaded single-row or suture-bridging 
double-row (20) rotator cuff repair augmented with platelet-rich plasma fibrin membrane 
(102); arthroscopic rotator cuff repair with and without biceps tenodesis using the 
percutaneous intra-articular transtendon technique (PITT) (103); pulley exercises versus  
rehabilitation without pulleys after rotator cuff repair (104); open versus arthroscopic 
rotator cuff repair (105); Biceps tenotomy versus biceps tenodesis (106); intramedullary nail 
versus locking plate for proximal humeral fractur (107); arthroscopy-assisted versus 
standard intramedullary nail fixation for diaphyseal humerus fractures (108); reverse total 
shoulder arthroplasty as primary versus revision procedure for proximal humerus fractures 
(109); proprioceptive exercises in addition to conventional physiotherapy for impingement 
(110); intraoperative platelet rich plasma versus local anesthetic injection after arthroscopic 
rotator cuff repair (111); arthroscopic suprapectoral versus open sub-pectoral biceps 
tenodesis (112); addition of mesenchymal stem cells to suture repair of ruptured 
supraspinatus muscle tears (113); cement augmented locking plate versus proximal 
humerus nail for surgical neck proximal humerus fractures (114); arthroscopic soft tissue 
tenodesis at the  rotator interval versus bony interference fixation tenodesis at the distal 
bicipital groove for the long head of the biceps (115); 0.5ml versus 1ml type 1 atelocollagen 
intratendinous injection or no injection for small intratendinous partial thickness rotator 
cuff tear (116); suture-spanning augmentation of single-row repair for massive rotator cuff 
tears (117); biceps tenotomy versus tenodesis for long head of biceps lesions (118); 
arthroscopic bankart repair with and without arthroscopic infraspinatus remplissage for 
anterior shoulder instability (119); and Bankart repair with or without arthroscopic 
electrothermal capsulorrhaphy (120).
Critical appraisal of overall value to the rheumatology community
Strengths. The ASES score has good reliability, construct validity and responsiveness and has 
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Caveats and cautions. Mix of scales (binary, Likert, VAS). In the case where an MDC95% is 
reported to be higher than the MCID, the MDC95% should be taken as the MCID.
Clinical usability. Most studies include only the components of the patient self-assessment 
(pain and ADLs) used to derive an ASES score. This component is easy to understand, use 
and score.
Research usability. Good applicability for research and good responsiveness. It is 
recommended for use by the ASES Society and it is widely used, particularly in surgical trials.  
Constant (Murley) (CS) Score 
Description
Purpose. The CS was first described in a university thesis in 1986 and published in 1987 
(121). The score was originally conceived as an overall measure of the functional state of the 
shoulder in states of disease, injury, normal health, or after treatment, to be used in both 
clinical assessment and research. The development paper does not describe the rationale or 
method for item selection and weighting.
Modifications and guidelines for use were published by the original author in 2008 (122).
Self-administered versions of the CS have been proposed (in both English and French) (123, 
124), in which the two objectively-assessed subscales (range of motion and strength) are 
estimated by the patient using explanatory photographs (for ROM), and either measured or 
estimated using common household items of varying weight (for strength). 
Content or domains. There are four domains: pain, ADLs, shoulder range of motion and 
strength. Pain and ADLs are both patient-reported; range of motion and strength are 
measured by an examiner.
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Response options/scale. The pain subscale is a rating of the most severe pain experienced 
during normal activities over the preceding 24 hours and was originally a 4-item Likert scale 
(none = 15 points, mild = 10 points, moderate = 5 points, severe = 0 points), but was later 
modified to a 15cm visual analogue scale (scored in centimeters, rounded to the nearest 
integer) (122, 125). The VAS anchors are 15 = ‘no pain’ and 0 = ‘intolerable pain’; there are 
no internal markers.
In the ADL subscale, sleep is rated on a 0–2 scale (0 = disturbance every night, 1 = occasional 
disturbance, 2 = undisturbed). Work and recreational activities are each rated on a 15cm 
VAS in response to the question ‘how much of your normal work does your shoulder allow?’ 
and ‘how much of your normal recreational activity does your shoulder allow?’. Anchors are 
‘none’ and ‘all’. Each VAS response is measured in 3cm quintiles to give a score of 0–4. 
Functional mobility is rated according to the level that the patient can ‘use their hand 
comfortably’ on a 5-item scale scored from 2–10 in 2-point increments (‘up to waist’ = 2, ‘up 
to xiphoid’ =4, ‘up to neck’ = 6, ‘up to top of head’ = 8, ‘above head’ = 10). Some versions 
include a further response category (‘below waist’), allocated zero points (125).
Shoulder ROM is measured by the examiner as the maximum painless active movement in 4 
planes (forward elevation, lateral elevation, external rotation, internal rotation). Each 
movement is allocated up to 10 points, for a total ROM score of up to 40 points. Forward 
and lateral elevation are each measured with a goniometer in 30-degree increments (0–30, 
31–60, 61–90, 91–120, 121–150, >150 degrees), allocated 2 points for each increment from 
zero to 10 points. External rotation is measured according to the functional capacity to 
reach various anatomical landmarks, with 2 points allocated for each of five successful 
movements: ‘hand to back of head with elbow forward’, ‘hand to back of head with elbow 
back’, ‘hand to top of head with elbow forward’, ‘hand to top of head with elbow back’, ‘full 
elevation’. Internal rotation is measured by ability to reach anatomical landmarks with the 
thumb, in 2-point increments from zero to 10 points: ‘lateral aspect of thigh’, ‘behind the 
buttock’, ‘sacroiliac joint’, ‘level of the waist’, twelfth thoracic vertebra‘, interscapular level’.
Shoulder strength was originally described as the maximum resisted force with the arm at 
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held in the patient’s hand (or using a wrist cuff in patients with poor grip strength due to 
disease) (121). Various modifications to the original method have been made subsequently. 
The revised CS (122) used a proprietary isometric dynamometer (Isobex) attached via a 
wrist cuff to measure maximum force generated in a 5 second effort, with the shoulder at 
90 degrees abduction in the scapular plane and a pronated wrist. The score is the force in 
kilograms: 1 point per 0.5kg, to a maximum of 25 points.
Recall period for items. 24 hours for pain and one week for ADLs.
Cost to use. Free of charge. 




Method of administration. Patient written self-assessment (pen and paper) plus clinical 
examination.
Scoring. The CS is a 100-point scale comprising patient-reported data (35 points) and clinical 
assessment (65 points). Pain contributes up to a maximum of 15 points, ADLs up to 20 
points ( sleep 0–2, work 0–4, recreation 0–4, functional mobility 0–10), range of motion cup 
to 40 points and strength up to 25 points) (122). The total score is the sum of these four 
subscales.
Score interpretation. 0  = worst and 100  = best function. Individual subscales are not 
reported separately. The original description of the instrument by Constant and Murley was 
as a composite measure of shoulder function and deliberately included specified that pain 
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Comparison with the contralateral shoulder is possible, however this assumes an absence of 
pathology in the other shoulder. Normative data are available from a sample of 1620 clinic 
patients (1046 men, 573 women, age range 11 to 87) who reported one painless shoulder 
and a further 115 healthy volunteers (56 men, 59 women, age range 20 to 69) with no 
history of shoulder disorders or other illness (126). By definition, subjects were only 
included if they achieved a maximum score on the subjective measures (pain and ADLs). The 
mean total score (+/-SD) was 89 points (+/- 7) in clinic patients and 87 points (+/-5) in 
healthy volunteers. Mean scores were higher in men (91 – 92 points) than women (83 – 84 
points), p<0.01, with much of this difference accounted for by differences in strength. 
Scores declined progressively with age. There was no difference in scoring between 
experienced physician-researchers and novice resident physicians.
Respondent time to complete. The complete CS (including both patient-reported data and 
physical examination) takes less than 20 minutes (37). The self-reported component is 
relatively brief.
Administrative burden. Requires time to perform, however some of the examination 
maneuvers (particularly range of motion) may be incorporated in the normal physical 
examination. Some special equipment is needed, including a goniometer to measure range 
of motion and a dynamometer or similar device for measuring strength. No special software 
is required. Calculation of the score is straightforward.
Translations/adaptations. A German language version was published by Constant (127). 
Cross-cultural adaptations have been performed for several languages including Danish 
(125, 128), Turkish (129), Brazilian Portuguese (130), Greek (131) and Chinese (132).
Psychometric information
Floor and ceiling effects. No floor or ceiling effects for the total score were detected in 
patients with inflammatory or degenerative shoulder conditions referred for orthopaedic 
surgery (37), in Dutch patients with subacromial impingement or rotator cuff tears (133), or 
in patients undergoing total shoulder arthroplasty for glenohumeral osteoarthritis (134). 
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position their arm in the measurement position: 51.9% of patients with inflammatory or 
degenerative rheumatic diseases who were referred to a hospital for shoulder surgery 
received zero points for strength due to either pain or inability to reach the measurement 
position (37).
Reliability. Internal consistency (measured by Cronbach’s α) has been estimated to range 
from 0.37 in Korean patients undergoing surgery for various shoulder disorders (69), 0.60 in 
Canadian patients with mild to severe rotator cuff disease (135), to 0.8 in Dutch patients 
with subacromial impingement or rotator cuff tears (133).
Test-retest reliability is reported to be good to excellent. In French patients with painful 
rotator cuff disease, ICC = 0.92 (95% CI 0.82, 0.98) for the total CS score (including self-
reported and objective measures, using a single assessor) (136). In patients with rheumatoid 
arthritis, test-retest reliability for the total CS score was slightly higher when the same 
examiner was used (intra-tester ICC 0.95 - 0.96) than when two different experienced 
clinicians performed the assessment (inter-tester ICC 0.84 - 0.87) (137).
The strength testing component of the CS is a potential source of measurement error due to 
lack of standardisation of the testing procedure and equipment. In a sample of healthy 
volunteers, however, both intra-tester and inter-tester reliability was high when assessed by 
senior physiotherapy students with experience in use of this tool (intra-tester ICC 0.90 - 
0.98, inter-tester ICC 0.89 - 0.97) (138).
In some cases in which reliability or validity was tested in countries where English is not the 
primary language, it was not clear whether the English CS or a translated version was used 
(44, 69, 133, 136, 139).
Validity. The CS has been linked to seven second-level International Classification of 
Functioning, disability and health ICF categories, considerably fewer than other measures 
including DASH and ASES, but similar to SPADI (140). The seven categories represented two 
ICF components: “(b) Body Functions” (sleep functions, sensation of pain, mobility of joint 
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remunerative employment, recreation and leisure).  There is variation in the methods used 
for strength testing and no gold standard method exists. Variation in the position of the arm 
or the cuff during strength testing can result in substantial variation in force measurement 
(141).
Pearson’s or Spearman’s coefficients for correlation of the CS with other general and 
shoulder-specific outcome measures (and the population measured in) are as follows:
Standardized Index of Shoulder Function (FI2S): Various non-surgical and post-surgical 
shoulder disorders: r = 0.91 (142). 
Shoulder Function Index (SFInX): Proximal humeral fracture - baseline: r = 0.89 (143). 
OSS: Degenerative or inflammatory shoulder disease referred for surgery: r = 0.71 (37); 
patients undergoing surgery for rotator cuff disease: r = 0.65 (144); patients with a proximal 
humerus fracture: r =  0.53 (at 6 weeks) and 0.79 (at 12 weeks) (145). 
ASES: Patients undergoing surgery for various shoulder disorders: r = 0.36 (69); patients 
undergoing surgery for rotator cuff tears: r = 0.87 (72); patients enrolled in physical therapy 
for shoulder dysfunction: r = 0.495 (38). 
Penn Shoulder Score: Patients undertaking physical therapy for shoulder disorders: r = 0.85 
(54). 
SST: Patients undergoing surgery for various shoulder disorders: r = 0.52 (69); (after rotator 
cuff surgery): r = 0.49 (72) to 0.70 (146); patients enrolled in physical therapy for shoulder 
dysfunction: r = 0.65 (38). 
UCLA: Patients with a proximal humerus fracture: r =  0.70 (at 6 weeks) and 0.92 (at 12 
weeks) (145); patients undergoing surgery for various shoulder disorders: r = 0.67 (69); after 
rotator cuff surgery: r = 0.66 (146); patients enrolled in physical therapy for shoulder 
dysfunction: r = 0.59 (38). 
SPADI: Degenerative or inflammatory shoulder disease referred for surgery: r = 0.53 (37); 
(patients enrolled in physical therapy for shoulder dysfunction: r = 0.56 (38). 
DASH: Degenerative or inflammatory shoulder disease referred for surgery: r = 0.50 (37); 
patients undergoing surgery for rotator cuff tears) r = 0.76 (72); patients with a proximal 
humerus fracture: r =  0.62 (at 6 weeks) and 0.86 (at 12 weeks) (145); in German-speaking 















This article is protected by copyright. All rights reserved
Western Ontario Shoulder Instability (WOSI) Index: Patients undergoing surgery for various 
shoulder disorders: r = 0.18 (69); patients with symptomatic shoulder instability r = 0.59 
(147). 
WORC: Rotator cuff disease: r = 0.56 (148) to 0.65 (149). 
Bostrom’s shoulder movement impairment scale: Degenerative or inflammatory shoulder 
disease referred for surgery: r = 0.78 (37). 
Shoulder Function Assessment (SFA) scale: Degenerative or inflammatory shoulder disease 
referred for surgery): r = 0.86 (37). 
Short-Form 36 (SF-36) Physical Component Score: Patients undergoing surgery for various 
shoulder disorders: r = 0.41 (69). 
Agreement between the modified CS and patient-reported CS. In patients referred for 
shoulder surgery, mean scores were similar for clinician-assessed (mean 48, SD 20) and 
patient-assessed CS (mean 47, SD 19.5). Agreement between clinician assessors and 
patients was high for ROM (weighted Kappa 0.8-0.9) (124). In French patients with various 
shoulder disorders, correlation between the total CS score assessed by an orthopaedic 
surgeon and the ‘Auto-Constant’ assessed by the patient was ICC = 0.87  (123). Of the 4 
subscales, the ICC was lowest for the strength subscale (0.57) but highest for the ROM 
subscale (0.85).
Responsiveness. Reported ES and SRM in various shoulder conditions and settings are as 
follows:
Patients with rotator cuff disease seen in a tertiary orthopaedic clinic after 6 months: SRM = 
1.38 (149); one week after completion of a course of physical therapy plus acupuncture or 
mock TENs for painful rotator cuff disease: ES = 0.4 (150); after subacromial decompression 
surgery SRM = 1.12 and 2.09 at 3 and 6 months, ES = 1.23 and 1.92 at 3 and 6 months (151); 
six months following surgery for various shoulder disorders: SRM = 0.58, ES = 0.57 (69); two 
to five years after total shoulder arthroplasty for osteoarthritis: SRM = 2.4, ES = 2.9 (134); six 
months after total shoulder arthroplasty: SRM = 1.99, ES = 2.23 (44); and at three months in 
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Minimally important differences. The MDC in Dutch patients with subacromial 
impingement or rotator cuff tears was 23 points (133). Reported MCIDs range between 8 
and 17 points. It was 8 points for patients at one year following reverse shoulder 
arthroplasty for cuff arthropathy (152);  9.4 points at 44 months after shoulder arthroplasty 
for glenohumeral arthritis or cuff arthropathy (153); 10.4 points at 3 months after 
arthroscopic repair of rotator cuff tear (154); 11 points after three months of physical 
therapy following arthroscopic decompression surgery in Danish patients (139); and 17 
points after three months of exercise therapy for ‘subacromial pain’ (155).
Generalizability. The CS has been tested in healthy subjects and in people with various 
shoulder pathologies including rotator cuff disease, proximal humeral fractures, 
glenohumeral arthritis, shoulder instability and adhesive capsulitis.
Use in clinical trials. The CS is one of the most widely used instruments in clinical trials for 
shoulder disorders with almost 130 reported up to December 2015 (2). Examples of trials 
which have used the CS as an outcome measure in the last five years include various surgical 
interventions (for conditions including rotator cuff tears (156), proximal humeral fracture 
(157), osteoarthritis (158), physical therapies (including heat therapy for shoulder pain 
(159), and other interventions (including suprascapular nerve blocks (160) and platelet-rich 
plasma injections (161) for rotator cuff tears, and glucocorticoid injections for adhesive 
capsulitis (162).
Critical appraisal of overall value to the rheumatology community
Strengths. The CS appears to be widely accepted within the clinical and research community 
and is frequently used. It covers several clinically-relevant domains. It is readily accessible 
and requires relatively little equipment. Normative data are available. Responsiveness 
appears to be acceptable in a variety of settings.
Caveats and cautions. Requires assessment in-person by a trained assessor; self-assessment 
versions have been developed but require further validation. Ambiguity in the description of 
the assessment tasks or inconsistent application of testing methods have the potential to 
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create some concern that the MDC may be higher than the MCID. There is evidence of 
variation in the methods and equipment used to measure strength, which may affect overall 
scores, and floor effects for strength exist when shoulder mobility is severely restricted. 
Clinical usability. The CS is commonly used in clinical practice, particularly surgical 
specialties, and in Europe. It is easily incorporated into routine clinical assessment, although 
some special equipment is required for strength testing.
Research usability. Concerns regarding reliability (particularly inter-tester reliability) are an 
important caveat for use in a research setting.
Simple Shoulder Test
Description
Purpose. To assess functional limitations of the shoulder relative to the patient’s activity of 
daily living before or after treatment, and work (163). Questions were derived from Neer’s 
evaluation (164), the American Shoulder and Elbow Surgeons (ASES) evaluation (52) and the 
most frequent complaints of patients observed in the shoulder practice at the University of 
Washington (163). Further details on how item content was selected have not been 
described. Item-response theory was applied later (165).
Content or domains: There are three domains: pain, function/strength and range of motion 
Number of items: 12 items (2 pain, 7 function/strength, 3 range of motion). 
Response options/scale: All yes/no responses for each item.
Recall period for items: At the moment of assessment.
Cost to use: Free of charge for non-commercial use.
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Practical application
Method of administration. Self-assessment.
Scoring. Original score: 0 = worst and 12 = best. Transformed by summing the number of 
‘yes’ answers/number of completed items X 100 = percent ‘yes’ responses. 
Score interpretation. 0 = worst and 100 = best function. A missing rule or distinct cutoffs for 
severity, and normative data have not been published. There are no subscales.
Respondent time to complete. 2–3 minutes.
Administrative burden. Free online. Score computation is very easy and possible by hand. 
No software needed. Time to administer and determine is estimated to be 5 minutes.
Translations/adaptations. The SST has been translated, adapted, and validated in Dutch 
(166), Brazilian Portuguese  (167), Spanish (168), Persian (169), Italian (170) and Lithuanian 
(171).
Psychometric information
Floor and ceiling effects. A range of floor and ceiling effects have been across a range of 
shoulder conditions  (36, 64, 166, 169, 172, 173). Floor and ceiling effects were found in 
1.2% and 5.1% of patients with rotator cuff diseases and 2% and 9.3% of patients with 
shoulder instability in one study (172); 21% floor and 6.1% in a study of people with rotator 
cuff disease (172); and no floor and 15.3% ceiling effects in patients who had undergone 
shoulder arthroplasty (173). No floor or ceiling effects were found in Iranian patients with a 
variety of shoulder disorders (169) while 1.8% floor and 13.6% ceiling effects were observed 
among Dutch patients with various shoulder disorders (166).
 
Reliability. Estimates of the internal consistency of the SST have been reported across 
various patient populations: patients with various shoulder complaints: Cronbach’s  = 0.85 �
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to 0.86) (167); Dutch patients with shoulder problems attending an orthopaedic clinic: 
Cronbach’s  = 0.78 and removing items from the questionnaire did not result in higher �
Cronbach’s  (166); Italian patients after surgery for anterior instability”: Cronbach’s  = � �
0.87 (170); Iranian patients with a variety of shoulder disorders: Cronbach’s  = 0.73 (169); �
One study reported that the SST was unidimensional with 8.4% unexplained variance (64). 
However while the STT was designed to measure a single construct, some factor analyses 
have questioned this, and have more commonly identified two- or three-factor solutions. 
One factor analysis of the English version SST from a sample of patients with shoulder 
complaints revealed a 2-factor solution which explained 52.6% of the variance (29). Two 
items relating to ability to sleep comfortably and comfort at rest which are both influenced 
by the amount of pain a person is experiencing showed misfit.  In another Rasch analysis, 
three items were considered misfit in data obtained from patients following shoulder 
arthroplasty or rotator cuff repair surgery (174). However this study found that the SST was 
unidimensional and that it was not the reason for the misfit of items. Across the entire 
continuum of shoulder functioning, function was not measured with equal precision but 
with very large confidence intervals, i.e., larger than the ASES and Shoulder Pain and 
Disability Index (SPADI)(165). 
Moderate fit with one factor was identified in the Dutch version (166), however three-factor 
solutions have been found in the Persian (169), Brazilian Portugese (167) and Spanish (168) 
versions. A 3-factor solution, mainly related to activities performed with the arm at shoulder 
level (arm elevation), shoulder movement and arm strength, and which explained 49.7% of 
variance, was identified in the Persian STT (169). The Cronbach’s  for these three factors �
were 0.7, 0.53, and 0.6 respectively. For the Brazilian Portugese STT tested in patients with 
various shoulder problems a 3-factor solution explained over 40% of the variance and 
Cronbach’s  was 0.82 for the overall test, 0.82 for both arm elevation and shoulder �
movement subscales, 0.81 for comfort in rest subscale and 0.59 for the overall global 
shoulder function value (167). For the Spanish version tested also tested in patients with 
various shoulder problems a 3-factor structure explained 56.12% of the variance with 
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Test-retest reliability of the SST is high. One study reported ICCs of 1 (95% CI 1 to 1) and 
0.97 (95% CI 0.91 to 0.99) measured in patients with instability and rotator cuff disease 
respectively (172); in a study of patients attending a surgical clinic: ICC = 0.99 (31); in studies 
of Dutch patients with shoulder complaints: ICC = 0.86 (175) and 0.92 (166); in Italian 
patients after surgery for instability: ICC = 0.97 (170); in patients with various shoulder 
problems in Iran: ICC= 0.94 (95% CI 0.86 to 0.97 (169), in Spain: ICC 0.912 (168)
Validity. Pearson’s or Spearman’s coefficients for correlation of the STT with other general 
and shoulder-specific outcome measures (and the population measured in) are as follows:
SPADI: Various shoulder problems: ICC = 0.74 and 0.80 (29, 36); Italian patients after 
shoulder surgery for anterior instability: ICC = 0.68; pain subscale ICC = 0.63 and function 
subscale ICC = 0.72 (170)
ASES: Various shoulder problems: 0.73 (36) and 0.536 (64);  rotator cuff diseases: 0.76 (172); 
instability: 0.89 (172); Italian patients after shoulder surgery for anterior instability: ICC = 0.8 
(170). 
OSS: general shoulder problems in Dutch patients: ICC = 0.61 (176) and ICC = 0.74 (166), and 
Iranian patients ICC = 0.68 (169); Italian patients after shoulder surgery for anterior 
instability: ICC = 0.67 (170)
DASH: Rotator cuff surgery: 0.72 (42); various shoulder problems in Spanish patients:ICC = 
0.73 (168) and Dutch patients: ICC = 0.74 (166)
CS: Rotator cuff surgery: 0.70 (146) 
Western Ontario Rotator Cuff (WORC) index: Rotator cuff surgery: 0.68 (42), various 
shoulder problems: SF-36 bodily pain: 0.62 (36)
UCLA: Italian patients after shoulder surgery for anterior instability: pain subscale ICC = 0.61, 
function subscale ICC = 0.51 (170)
WOSI: Italian patients after shoulder surgery for anterior instability: ICC = 0.63 (170).
Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function 
Computerized Adaptive Test(PF CAT): Patients been seen by a shoulder and elbow surgeon: 
0.635 (64)
SF-36 physical functioning: various shoulder problems: 0.58 (36) and 0.56 (166)
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SF-12 PCS: various shoulder problems:  0.44 (172)  and in Spanish patients: 0.43 (168)
SF-36 Mental Component Summary (MCS) score: Rotator cuff surgery: 0.16 (42) 
Responsiveness. Effect sizes (ES) and standardized response means (SRMs) of the SST are as 
follows:
Shoulder arthroplasty: ES 2.17–2.87, SRM 1.43-2.05 (173, 177)
Rotator cuff repair: SRM 1.09 (42)
Rotator cuff surgery: ES 1.08, SRM 1.01 (172)
Rotator cuff surgery + total shoulder arthroplasty: SRM 0.87 (31)
Instability surgery: ES 0.61, SRM 0.63 (172)
After shoulder arthroplasty: ES 2.29, SRM 2.05 (173)
Minimally important differences. Minimally detectable change (MDC95%) across various 
shoulder problems is 32.3% (0-100% scale)(29), after surgery for shoulder instability in 
Italian patients 1.12 (0-100% range)(170) and 2.8 points (0-12 scale)(175). In Spanish 
patients with various shoulder problems: MDC90 = 6.2% (0 to 100% scale) (168); in Iranian 
patients with shoulder disorders: MDC = 3.7 (0 to 12 scale)(169); and in Dutch patients with 
various shoulder problems: MDC 3.3 (0 to 12 scale (166). 
MCID is reported for the following shoulder conditions:
Rotator cuff disease using fifteen-item function question as anchor question:2.05 and using 
four-item improvement question as anchor question: 2.33 points (0–12 range) (78).
Shoulder arthroplasty 3 and 2.4 points (0–12 range) (79, 177).
Various shoulder problems: 2.2 points (0–12 range) or 17.1–25.0 (0–100 range) (175).
Generalizability. This measure is shoulder-specific but has also been used to measure 
shoulder function in patients with other conditions, e.g., following surgery for breast cancer 
(30). It has also been translated and culturally adapted in various countries.
Use in clinical trials. Up to December 2015 the SST had been used in 17 randomized 
controlled trials (2). Examples of trials that have used the SST to measure outcome in the 
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versus open stabilization for anterior shoulder subluxations (100), multimodal analgesia 
injection combined with corticosteroids after arthroscopic rotator cuff repair (96), pulley 
exercises versus  rehabilitation without pulleys after rotator cuff repair (104), precut 
kinesiology tape versus oral NSAIDs for impingement syndrome (178), arthroscopic release 
versus manipulation under anesthesia for frozen shoulder (179), Interference screw versus 
and suture anchor fixation for biceps tenodesis (97), arthroscopic bankart repair with and 
without arthroscopic infraspinatus remplissage for anterior shoulder instability (119), 
tenotomy versus tenodesis for long head of biceps tendon lesions (180) and arthroscopic 
rotator cuff with or without acromioplasty (87).
Critical appraisal of overall value to the rheumatology community
Strengths. Very short and easy to use. Good construct validity with function subscales and 
good reliability, and acceptable floor and ceiling effects. 
Caveats and cautions. Due to the binary response options, the use of the SST score as a 
metric measure is questionable. In the case where an MDC95% is reported to be higher than 
the MCID, the MDC95% should be taken as the MCID. However, more studies are needed to 
compare the MDC95% with the MCID within similar populations and contexts. Construct 
validity is better when correlating SST with other shoulder specific measures, rather than 
with generic measures, SST can measure shoulder function, but cannot infer overall health 
of the shoulder.    
Clinical usability. Easy to use; widespread use in the US and also translated and culturally 
adapted to many different countries. 
Research usability. This measure is widely used due to its convenience and ease of use. 
However, we recommend it is used with caution because of its identified caveats. Further 
testing is needed to fully understand its psychometric properties for various patient groups.
















This article is protected by copyright. All rights reserved
Purpose. The OSS was developed to be a self-assessment of pain and function of the 
shoulder assessing outcome from shoulder surgery other than shoulder stabilization (181). 
The original version was published in 1996 and a ‘revision’ published in 2009 clarified 
specifications for its use but only altered the method of scoring each item (182). A 22-item 
questionnaire was developed based upon interviews with patients attending an outpatient 
shoulder clinic as well as from established questionnaires (181). Another set of patients 
completed the draft questionnaire and were also invited to provide comments including 
identifying any further shoulder problems that had been omitted. Further testing over 
several steps resulted in the 12-item version. Factor analysis or item response theory was 
not used.
Content or domains. There are two domains: pain and daily functions. There are no 
subscales.
Number of items. 12 items (2 pain, 2 interference with pain and 8 daily functions).
Response options/scale. In both the original and revised versions there are five response 
options for each item. The original version: 1 - no pain/easy to do, 2 - mild pain/little 
difficulty, 3 - moderate pain/moderate difficulty, 4 - severe pain/extreme difficulty, and 5 - 
unbearable/impossible to do (range is 1 best to 5 worst) (181). 
In the revised version, each the 12 items are scored from 0 to 4 instead of 1 to 5 and the 
direction of the scores were also reversed: 0 (worst) to 4 (best)(182). 
Recall period for items. 4 weeks.
Cost to use. Free of charge for non-commercial use: fees for commercial users and 
academic studies that are funded by a commercial entity.
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Practical application
Method of administration. Self-assessment.
Scoring. In the original OSS the (total) score is the sum of the (completed) 12 items (scoring 
1–5): 12 = best and 60 = worst (181). In the revised version, the (total) score is also the sum 
of the 12 items (scoring 0 to 4) but the scores are reversed, with score ranges from 0 = 
worst to 48 = best (182). There are no subscales.
At least 10 of the 12 items have to be completed (182). If only one or two questions have 
been left unanswered, the mean value representing all of the other responses can be 
entered to fill the gap/s. If more than two questions are unanswered, calculating an overall 
score is not recommended. If patients indicate two answers for one question, by convention 
it is recommended that the worst (most severe) response is adopted.
Score interpretation. In the original OSS, a score of 12 indicates no disability while a score 
of 60 indicates maximal disability. In the revised OSS (and online form), a score of 0 
indicates maximal disability while a score of 48 indicates no disability. A score of 0–19 
indicates severe arthritis, 20–29 moderate to severe arthritis, 30–39 mild to moderate 
arthritis, and 40–48 satisfactory joint function. 
Normative data for the OSS scale (range 0-48) in 635 asymptomatic, healthy volunteers in 
Australia (N=323) and Canada (N=312) are available (9). Participants were excluded if they 
had a history of active shoulder pathology or a history of recent surgery (within the last 
three years) or joint arthroplasty. People without a history of shoulder pathology reported 
higher (better) mean OSS scores compared with those with a history of a shoulder problem 
(46.8 versus 46.1, Wilcoxon rank sum test p=0.0013). No differences in scores were 
observed in people with and without a current wrist or elbow problem or handedness. 
There was no difference between genders adjusted for nationality (mean 47 in both). Mean 
score declines with increased age. 
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Administrative burden. Score computation is easy and needs no explanation. No training is 
needed to administer and interpret the scores. Can be completed using pen and paper. 
Time to administer and score ~ 5 minutes.
Translations/adaptations. The OSS has been translated and culturally adapted to Dutch 
(176), Italian (170, 185), German (187), Brazilian Portuguese (188), Korean (183), French 
(189), Turkish (40), Chinese (190), Persian (169), Spanish (30), Romanian (184), Danish (191) 
and Polish (192). 
Psychometric information
Floor and ceiling effects. No floor or ceiling effects have been reported in a mixed 
population of patients (most with rheumatoid arthritis or osteoarthritis) undergoing 
glenohumeral or acromioclavicular surgery (37) or in patients with mixed shoulder 
complaints in Iran (169), China (190) or Turkey (40). In one study in Korean patients with 
degenerative or inflammatory shoulder disorders floor and ceiling effects of 0.1% and 8.5% 
respectively were reported (183). 
Reliability. The OSS has acceptable internal consistency with numerous studies in varying 
populations reporting Cronbach’s α of 0.89 or above in both original and translated 
versions: pre-operative mixed population excluded patients with instability: Cronbach’s α = 
0.89; subset of same population 6 months following various types of surgery: Cronbach’s α = 
0.89; all items correlated with the total score (r > 0. 4) (181); impingement syndrome with 
or without rotator cuff tear or calcific tendinitis: Cronbach’s α = 0.94 (187); mixed 
population of patients (most with rheumatoid arthritis or osteoarthritis) undergoing 
glenohumeral or acromioclavicular surgery: Cronbach’s α = 0.843 (37); Spanish patients with 
shoulder pain/dysfunction after surgery for breast cancer: Cronbach’s α = 0.947 (30); 
current shoulder symptoms in Persian patients: Cronbach’s α = 0.91 and if an item deleted it 
ranged from 0.91 to 0.92 (169); impingement or calcific tendinitis in German patients: 
Cronbach’s α = 0.94 and Cronbach’s α not below 0.93 when single items were eliminated 
(187); degenerative or inflammatory shoulder conditions in Italian patients: Cronbach’s α = 
0.95 (185); shoulder problems in Turkish patients: Cronbach’s α = 0.92 (40), French patients: 
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patients: Cronbach’s α = 0.96 (192); degenerative or inflammatory shoulder conditions in 
Korean patients: Cronbach’s α = 0.91 (183) and Brazilian patients: Cronbach’s α = 0.90 (186); 
Brazilian patients with rheumatoid arthritis: Cronbach’s α = 0.957 (188); and in Romanian 
patients with rotator cuff disorders or proximal humerus fractures: Cronbach’s α = 0.954 
(184). 
Factor analysis of the Persian OSS found a 2-factor solution which explained 61.6% of 
variance which is consistent with it being a two-dimensional outcome measure assessing 
pain and function (169). Principal component analysis of the Chinese OSS found a one factor 
structure which accounted for 54.2% of total variance (190).
Test-retest reliability is also reported to be acceptable: pre-operative mixed population 
excluded patients with instability: Coefficient of reliability 6.8 (Bland and Altman method) 
(181); impingement with or without rotator cuff tear or calcific tendinitis: Pearson’s 
correlation: 0.98 (187); impingement: weighted kappa = 0.13 for item 1, weighted kappa 
values for other items = 0.44-0.79 (39). Assessment of the Spanish OSS in patients with 
shoulder pain/dysfunction after surgery for breast cancer reported an ICC of 0.974 (30); 
Persian OSS in patients with current shoulder symptoms: ICC = 0.90 (95% CI 0.77 to 
0.95)(169); Danish OSS in patients with shoulder symptoms: ICC = 0.98 (191); German OSS in 
patients with impingement or calcific tendinitis: ICC = 0.98 (187); Dutch and French versions 
of the OSS in patients with general shoulder problems: ICC = 0.981 (176) and 0.91 (95% CI 
0.88 to 0.94) (189) respectively; Polish OSS post rotator cuff surgery: ICC = 0.99 (192); 
Korean OSS in degenerative or inflammatory shoulder conditions: ICC = 0.95 (183); Chinese 
OSS in non-specific shoulder pain patients: ICC = 0.97 (190); rotator cuff disorders and 
proximal humerus fractures in Romanian patients: ICC = 0.953 and ICC = 0.976 as the 
average ICC of the office visit and two days from the office visit (184); In Turkish patients 
with mixed shoulder complaints: ICC = 0.99 (40); Brazilian patients with degenerative or 
inflammatory shoulder conditions: ICC = 0.92 (186) or rheumatoid arthritis: ICC = 
0.917)(188).
Validity. Pearson’s or Spearman’s coefficients for correlation of the OSS with other general 















This article is protected by copyright. All rights reserved
CM: Mixed population of shoulder conditions pre- and post-surgery: -0.74 and -0.75 
respectively (181); impingement with or without rotator cuff tear or calcific tendinitis: 0.66 
(187), mixed population of patients (most with rheumatoid arthritis or osteoarthritis) 
undergoing glenohumeral or acromioclavicular surgery: 0.71 (37); proximal humeral fracture 
treated conservatively: 0.84, 0.77 and 0.87 at baseline and 3 and 12 months follow up (193); 
impingement or calcific tendinitis in German patients: 0.60 (187); general shoulder 
problems in Dutch: ICC = 0.64 (176), French: 0.73 (189) and Chinese patients: 0.66 (190); 
degenerative or inflammatory shoulder conditions in Italian patients: ICC = 0.73 (185); 
Danish patients with shoulder complaints: ICC = 0.74 (191); rotator cuff disease prior to 
surgery and 6 months post surgery: ICC = 0.65 and 0.65 (144); and Brazilian patients with 
rheumatoid arthritis (188). Correlation with the ADL, strength and range of motion 
subscales of the CM in Korean patients with degenerative or inflammatory shoulder 
conditions was ICC = 0.68, 0.48 and 0.42 respectively (183).
SPADI: mixed population of patients (most with rheumatoid arthritis or osteoarthritis) 
undergoing glenohumeral or acromioclavicular surgery: 0.74 (37); subacromial 
impingement: 0.85 (39); Spanish patients with shoulder pain/dysfunction after surgery for 
breast cancer: -0.674  (30): mixed shoulder complaints in Turkish patients: total, pain and 
disability subscales: ICC = -0.74, 0.71 and 0.72 respectively (40); patients attending a 
specialist shoulder clinic with subacromial impingement): r = 0.85 (39); and Italian patients 
after surgery for anterior instability: ICC = 0.79 (170). 
DASH: mixed population of patients (most with rheumatoid arthritis or osteoarthritis) 
undergoing glenohumeral or acromioclavicular surgery: ICC = 0.79 (37); patients with 
degenerative or inflammatory shoulder conditions in Brazil: ICC = 0.77, DASH work: ICC = 
0.76, DASH sport/music: ICC = 0.62 (186) and in Korea DASH disability/symptoms ICC = 
0.81,DASH work: ICC = 0.69, and DASH sport/music: ICC = 0.59 (183). QuickDASH: post 
rotator cuff surgery in Polish patients: -0.92 (192); rotator cuff disorders and proximal 
humerus fractures in Romanian patients: ICC = 0.633 and 0.672 two days later (184).
SST: current shoulder symptoms in Persian patients: 0.68 (169); general shoulder problems 
in Dutch patients: ICC = 0.61 (176) and ICC = and 0.74 )(166); and in Italian patients after 
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Shoulder Function Assessment scale: mixed population of patients (most with rheumatoid 
arthritis or osteoarthritis) undergoing glenohumeral or acromioclavicular surgery: ICC = 0.72 
(37)
Subjective Shoulder Value (SSV): general shoulder problems in French patients: ICC = 0.68 
(189).
UCLA: degenerative or inflammatory shoulder conditions in Italian patients: ICC = 0.67 (185)
SF-36 bodily pain: Mixed population of shoulder conditions pre- and post-surgery: ICC = -
0.66 and -0.68 respectively (181); subacromial impingement: ICC = 0.69 (39); impingement 
with or without rotator cuff tear or calcific tendinitis: ICC =  0.76 (187); post rotator cuff 
surgery in Polish patients: 0.81 (192); rotator cuff disease prior to surgery and 6 months 
post surgery: 0.64 and 0.75 (144); non-specific shoulder pain in Chinese patients: ICC = 0.53 
(190); degenerative or inflammatory shoulder conditions in Italian patients: ICC = 0.66 (185); 
mixed shoulder complaints in Turkish patients: ICC = 0.74 (40); Brazilian patients with 
rheumatoid arthritis: 0.624 (188); and Italian patients after surgery for anterior instability: 
pain subscale 0.7 and function subscale 0.54 (170).
SF-36 physical function: Mixed population of shoulder conditions pre- and post-surgery: -
0.61 and -0.62 respectively (181);  impingement with or without rotator cuff tear or calcific 
tendinitis: 0.62 (187); subacromial impingement: 0.57 (39); post rotator cuff surgery in 
Polish patients: 0.82 (192); non-specific shoulder pain in Chinese patients: ICC = 0.65 (190); 
rotator cuff disease prior to surgery and 6 months post surgery: -0.57 and 0.68 (144); mixed 
shoulder complaints in Turkish patients: ICC = 0.63 (40); degenerative or inflammatory 
shoulder conditions in Italian patients: ICC = 0.74 (185); and in Brazilian patients with 
rheumatoid arthritis: ICC = 0.589 (188).
SF-36 physical component summary: mixed shoulder complaints in Turkish patients: 0.63 
(40); post rotator cuff surgery in Polish patients: ICC = 0.82 (192).
Health Assessment Questionnaire (HAQ): Mixed population of shoulder conditions pre- and 
post-surgery: pain subscale 0.49 and 0.71 and function subscale 0.86 and 0.80 respectively 
(181); Brazilian patients with rheumatoid arthritis: 0.663 (188). 
One study assessed correlation of the OSS with other shoulder measures in people without 
current shoulder complaints: ASES: r = 0.71; CM: r = 0.44; UCLA: r = 0.8; SPADI: r = 0.78; and 
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Responsiveness. Effect sizes (ES) and standardized response means (SRMs) of the OSS have 
reported across various populations and settings as follows:
Mixed population of patients with shoulder conditions planning to undergo surgery: ES 1.2 
(181); mixed population of patients undergoing hemiarthroplasty: osteoarthritis with intact 
rotator cuff: ES 2.9, osteoarthritis with a torn rotator cuff: ES 2.1 and rheumatoid arthritis: 
ES 3.1 (194); mixed population of patients undergoing subacromial decompression with or 
without rotator cuff repair: ES ranged from 1.88 (full rotator cuff repair), 0.14 (partial 
repair), 1.02 (no repair), 1.55 (no tear)(195); subacromial impingement (regardless of 
treatment): ES: baseline to 6 weeks and 18 weeks: ES 0.24 and  0.96 (39); mixed population 
of patients (most with rheumatoid arthritis or osteoarthritis) undergoing glenohumeral or 
acromioclavicular surgery: ES 0.61 (37); and in Spanish patients with shoulder 
pain/dysfunction after surgery for breast cancer: ES 0.50, SRM = 0.70 (30). 
Minimally important differences. An MDC of 3.15 points was reported in a study of Polish 
patients post rotator cuff surgery (192) while an MDC of 7.18 was reported in a study of 
Brazilian patients with degenerative or inflammatory shoulder conditions (186). Both a 
smallest detectable change (SDC) and MCID of 6 points (OSS scale 0 to 48 points) was 
reported in a study including patients with shoulder problems attending an orthopedic 
outpatient clinic (baseline and 6 months follow up, both surgery and non-operative 
treatment, excluding fractures and frozen shoulder) (175). Another study also reported an 
MCID of 6 points that included patients following subacromial decompression (139). An 
MCID of 6.9 points for the original 12 to 60 point scale was reported in a study including a 
mixed population of patients (most with rheumatoid arthritis or osteoarthritis) undergoing 
glenohumeral or acromioclavicular surgery (196). An MCID of 18.8 on a 0-100 scale was 
reported in Persian patients with general shoulder problems (169).
Generalizability. Since the previous review there have been many further studies evaluating 
the psychometric properties of the OSS. It has been widely translated and adapted into 
different languages and cultural settings and it has been used widely to assess outcome 
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conditions including glenohumeral or acromioclavicular arthritis, rotator cuff disease, 
proximal humerus fractures and adhesive capsulitis.  
Use in clinical trials. Up to the end of 2015 the OSS had been used in seven randomised 
controlled trials (2). The OSS continues to be used as an outcome in trials published in the 
last five years including: surgical versus non-surgical treatment for proximal humerus 
fractures (197); intra-operative platelet-rich plasma versus local anesthetic injection for 
arthroscopic repair (111); ultrasound added to exercise and mobilization for frozen shoulder 
(198); supervised versus home exercise for frozen shoulder (199); cement augmented 
locking plate versus proximal humerus nail for surgical neck proximal humerus fractures 
(114); arthroscopic subacromial decompression versus placebo for subacromial shoulder 
pain (200); arthroscopic suprapectoral versus open sub-pectoral biceps tenodesis (112); 
ultrasound-guided needling and lavage with or without glucocorticoid injection versus 
placebo for calcific tendinitis (201); addition of platelet-rich plasma applied to tendon repair 
site after double-row arthroscopic supraspinatus repair (202); extracorporeal shock wave 
therapy with or without kinesiotaping for calcific tendinitis (203); arthroscopic implantation 
of a subacromial balloon spacer for treating massive rotator cuff tear (204); stemmed versus 
stemless total shoulder arthroplasty for glenohumeral osteoarthritis (205); reversed total 
shoulder arthroplasty versus non-operative treatment for displaced proximal humerus 
fracture (206).
Critical appraisal of overall value to the rheumatology community. 
Strengths. This is a very short and responsive tool, with good internal consistency.  It is easy 
to complete and to score. Guidelines for interpreting the scores are clear and minimal floor 
or ceiling effects have been observed. This is a tool that was specially designed for surgical 
interventions. Construct validity to other measures is good and there is no cost for non-
commercial purposes. This tool has been translated and culturally adapted to many 
countries.
Caveats and cautions. As the MDC is similar to the MICD, caution is necessary for 
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the OSS is a two-dimensional outcome measure but is used as a single scale without 
subscales.
Clinical usability. It is a short and easy-to-use tool for assessment of shoulder surgery. 
Scores are easy to interpret. 
Research usability. The OSS continues to be widely used in clinical trials investigating both 
non-operative and surgical interventions for people with shoulder conditions. 
DISABILITIES OF THE ARM, SHOULDER, AND HAND QUESTIONNAIRE (DASH) AND ITS 
SHORT VERSION (QUICKDASH)
Description
Purpose. The DASH was developed for self-assessment of symptoms and function of the 
entire upper extremity in patients with pain in the arm, shoulder or hand (207). Draft items 
were identified by literature review (821 reduced to 67 (+3 new) due to content overlap or 
off target by a consensus group). Patient data were analyzed by different item to total 
correlation techniques, comparison to clinimetric ranking and clinical judgment, resulting in 
the final 30-item version (207, 208). The newest manual contains extensive psychometric 
information (207). Psychometric analysis by item-response theory (using Rasch analysis) was 
performed later for the DASH (209, 210). 
A shortened version called the QuickDASH (11 items) was published in 2005 (211) and the 
QuickDASH-9 (9 items) in 2009 (212). All relevant modern strategies were used in the 
development of the QuickDASH comparing 3 strategies: the concept-retention method, the 
equidiscriminative item-total correlation, and the item-response theory (Rasch modelling). 
The concept retention method was most similar to the DASH and was chosen to build the 
QuickDASH (211).
Content or domains. There are two domains: symptoms and function. 
Number of items. The 30 items in the DASH are comprised of 6 items about symptoms (3 
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function, 3 social/role function). Two optional additional modules for work (4 items) and 
sports/performing arts (4 items) are more rarely used in patient settings, but are used when 
assessing manual workers and athletes. The QuickDASH has 11 items (3 symptoms, 8 
function)(211). The QuickDASH-9 has 9 items (1 pain, 8 for function) (212), is rarely used and 
not supported by the authors of the original questionnaire (207).
Response options/scale. All items are scored on a scale of 5 (Likert) levels: 1 = no 
difficulty/symptoms, 2 = mild difficulty/symptoms, 3 = moderate difficulty/symptoms, 4 = 
severe difficulty/symptoms, and 5 = extreme difficulty (unable to do)/symptoms.
Recall period for items. 1 week.
Cost to use. Free of charge for non-commercial use; license for commercial use available at 
the Institute for Work and Health (IWH). Details on commercial use licence and costs can be 
found online (http://www.dash.iwh.on.ca/licences). Manual (3rd edition) online and paper 
copy (http://www.dash.iwh.on.ca/dash-manual).
How to obtain. Property and copyright at the IWH (online at http://www.dash.iwh.on.ca/). 
The links for the DASH and QuickDASH can be downloaded from the IWH website 
(http://www.dash.iwh.on.ca/about-dash) and (http://www.dash.iwh.on.ca/about-
quickdash). Language versions are online at http://www.dash.iwh.on.ca/available-
translations. 
Practical application
Method of administration. Self-assessment, with paper and pencil or computer.
Scoring. The arithmetic mean of at least 27 of the 30 items (missing rule) is transformed by 
(mean - 1) x 25 into the scale from 0 = no symptoms/full function to 100 = maximal 
symptoms/no function for the DASH total score (207). Five of 6 items are necessary for 
determination of the symptoms score and 22 of 24 items for the function score. Similarly, 10 
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function (211). Determination of the subscores for symptoms and function is possible (28, 
209, 210, 213, 214)., but this is not originally described (207).  
Computer scoring is not necessary but easier, e.g., on Microsoft Excel or any calculation or 





Score interpretation. Originally, 0 = best and 100 = worst. The reverse scale from 0 = worst 
to 100 = best by (100 - original score) is also often used for comparison with other scores 
such as the SF-36. Several studies have showed varying distinct cut-off points to reflect 
severity. One example is cut-off scores of <15 = “no problem,” 16–40 = “problem, but 
working,” and >40 = “unable to work” (207).
Normative values of 1,706 persons in the US general population, stratified by sex, age, and 
comorbidity, are available (US population mean 10.1 (SD 14.7))(28, 207, 215).
Respondent time to complete. Time to complete is 4 minutes for the DASH and 2 minutes 
for the QuickDASH (28, 207, 211, 214). All items are easy to read and comprehend and are 
not emotionally sensitive with the exception of item 21 which asks about sexual activity. 
This item is often left out by patients. For that reason, item 21 was not included in the 
QuickDASH (28, 211).
Administrative burden. Item rating can be typed or scanned into an electronic database. 
Score computation is easy (see above) and missing data are rare (<10%)(209) other than 
item 21, on sexual activity, which has high level of missingness (up to 30%) (211, 216, 
217).The questionnaire contains instructions on how to complete it. Time to administer 
(including control of missing data): DASH, 10 minutes; QuickDASH, 8 minutes. Little special 















This article is protected by copyright. All rights reserved
Translations/adaptations. Available for free for >50 languages and dialects 
(http://www.dash.iwh.on.ca/available-translations). Translations and cross-cultural 
adaptations have followed strict guidelines. (http://www.dash.iwh.on.ca/translation-
guidelines). Versions in 20 other languages are in progress (as of January 6, 2020).
Psychometric Information
Floor and Ceiling effects. Very low floor or ceiling effects have been reported. In most 
studies no floor or ceiling effects were reported, while 2 studies showed 0.5% and 1.8% 
ceiling effects for the DASH and 3% for the QuickDASH, and one study reported 2% of floor 
effects (28, 209, 210, 216, 218-220). 
Reliability. The DASH has high internal consistency with Cronbach’s  = 0.92–0.98 for the 
DASH (207, 209, 210, 212, 221) and 0.92–0.95 for the QuickDASH (211, 222). High reported 
Cronbach’s  may point towards some redundancy in the DASH and Rasch analyses have 
shown some problems regarding the unidimensionality of the DASH score, containing 
groups of items that measure different constructs, such as impairment activity limitations, 
and participation restriction (210). 
A Rasch analysis in a population of patients with upper-extremity musculoskeletal disorders 
provide evidence that respondents were unable to discern the 5 response levels proposed 
(210). Additionally, an item misfit was found with the combination of conceptually disparate 
elements, such as ‘pain’, ‘difficulty sleeping’, ‘stiffness’, ‘tingling’, and ‘feeling less capable’ 
into a ‘symptom/disability’ total score. The two most misfitting items were 26 ‘Tingling’ and 
21 ‘Sexual activities’ (210). During the development of the DASH, neither clinimetric nor 
psychometric strategies selected these two items during the process of item reduction; they 
were added only after clinicians’ input (223). 
Rash analysis of the DASH has also been conducted in a population of patients with multiple 
sclerosis and showed that for a proportion of the items, the scoring function does not work 
as intended, as the patients’ responses were not consistent with those predicted by the 
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The DASH demonstrates high test–retest reliability with reported ICCs ranging from 0.89 to 
0.98 for the DASH (45, 136, 207, 216, 218, 220, 224) and 0.90 to 0.94 for the QuickDASH 
(211, 222, 225).
Validity. Pearson’s or Spearman’s coefficients for correlation of the DASH with other 
general and shoulder-specific outcome measures, and the population measured in, are as 
follows:
SPADI: Patients who had undergone shoulder arthroplasty: r = 0.93,(28); patients with 
glenohumeral arthritis or soft tissue disorders around the shoulder, predominantly rotator 
cuff tendinitis: r = 0.83 (SPADI function, no overall SPADI assessed)(216); patients with 
adhesive capsulitis, pre-treatment and 3 weeks after arthrographic joint distension: r = 0.55 
at baseline and r = 0.50 for 3-week change scores (35); impingement: r = 0.75,(220); 
subacromial pain syndrome referred to physical therapy: r = 0.82 for the 3-4-month change 
score (226). 
CM: Patients who had undergone shoulder arthroplasty: r = 0.82 (28)
Short Form-36 physical component summary (SF-36 PCS): post shoulder arthroplasty: r = 
0.67,(28); post rotator cuff tear repair: r = 0.50 for 6-month change scores (7); impingement: 
r = -0.59 (220); rheumatoid arthritis patients with shoulder complaints: r = -0.70 (218).
SF-12 PCS: proximal humeral fracture: r =-0.75 (224); musculoskeletal complaints of the 
neck, shoulder and/or arm in primary care: r = 0.61 (pain in shoulder, arm and hand only): r 
= 0.63 (pain in neck and shoulder), r = 0.61 (pain in neck, shoulder, arm and hand). r = 0.62 
(pain in shoulder, arm and hand) (227).
SF-36 MCS: post shoulder arthroplasty: r = 0.06 (28); post rotator cuff tear repair: r = 0.29 
for 6-month change scores (7); impingement: r = -0.17 (220); rheumatoid arthritis patients 
with shoulder complaints: r = -0.27 (218).
SF-12 PCS: musculoskeletal complaints of the neck, shoulder and/or arm in primary care: r = 
0.10 (pain in shoulder, arm and hand only), r = 0.19 (pain in neck and shoulder), r = 0.16 
(pain in neck, shoulder, arm and hand), r = 0.15 (pain in shoulder, arm and hand) (227)















This article is protected by copyright. All rights reserved
HAQ: Patients with adhesive capsulitis, pre-treatment and 3 weeks after arthrographic joint 
distension: r = 0.54 at baseline and r = 0.35 for 3-week change scores (35); rheumatoid 
arthritis patients with shoulder complaints: r = -0.88 (218)
SST: Patients undergoing operative repair of a rotator cuff tear: r = 0.72 for 6-month change 
scores (7)
WORC: Patients undergoing operative repair of a rotator cuff tear: r = 0.71 for 6-month 
change scores (7)
EuroQol-5D (EQ-5D): Patients with a proximal humeral fracture: r =-0.75 (224)
28-Joint Disease Activity Score (DAS28): rheumatoid arthritis patients with shoulder 
complaints: r = 0.42 (218)
Global disability rating: Patients with shoulder problems: r = 0.71, r = 0.67 3-month change 
after physiotherapy (45)
Correlation of the QuickDASH with other general and shoulder-specific outcome measures, 
and the population measured in, are as follows:
SPADI: Post shoulder arthroplasty: r = 0.84 (228)
SF-36 PCS: Post shoulder arthroplasty): r = 0.68 (228)
Responsiveness. Reported effect sizes (ES) and standardized response means (SRMs) of the 
DASH total score according to patient population are as follows: total shoulder arthroplasty: 
ES 1.19, SRM 1.22 points (44); arthroscopic acromioplasty: ES 0.9, SRM 0.5 points (221); 
shoulder problem, physiotherapy: ES 1.06, SRM 1.08 points (45); glenohumeral arthritis or 
soft tissue disorders around the shoulder, predominantly rotator cuff tendinitis, surgical 
intervention: ES 0.64, SRM 0.81 points (216); adhesive capsulitis, arthrographic joint 
distension: patients receiving treatment of known efficacy, ES 0.58, SRM 0.96 points; 
patients reporting ‘marked or moderate’ improvement, ES 0.55, SRM 0.91 points; patients 
reporting ‘marked improvement’, ES 0.83, SRM 1.45 points (35).
ES and SRMs of the QuickDASH total score according to patient population have been 
reported as follows: total shoulder arthroplasty: ES 1.26 (228); shoulder or hand complaints: 
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Minimally important differences. Reported MDC for the DASH ranges between 12 and 19 
points: patients with shoulder problems treated with physiotherapy: 12.2 points (45); 
glenohumeral arthritis or rotator cuff tendinitis treated surgically: 12.75 points (216); 
impingement, no treatment: 13.1 points (220) or physical therapy: 11.8 points; humeral 
shaft fracture treated both operative and non-operatively: 19 points (229); shoulder 
complaints, surgical and non-surgical interventions: 16.3 points (175).
Reported MCIDs range between 4.4 and 12.4, notably less than reported MDCs: humeral 
shaft fracture treated both operative and non-operatively: 6.7 points (229); impingement, 
physical therapy: 4.4 points (226); shoulder complaints, surgical and non-surgical 
interventions: MIC 12.4 points (175); shoulder problems treated with physiotherapy: 10.2 
points (45).
MDC and MCID reported for the QuickDASH include: Shoulder pain, physiotherapy: MDC 
11.2 percentage points, MCID 8.0 points (225), shoulder complaints, surgical and non-
surgical interventions: SDC 17.1 points, MCID 13.4 points (175).
Generalizability. The DASH has been used to assess outcome from various non-operative 
and surgical interventions in people with varying shoulder conditions including 
glenohumeral arthritis, rotator cuff disease, proximal humerus fractures, adhesive capsulitis, 
rheumatoid arthritis and multiple sclerosis. The availability of the DASH in so many 
languages adds to its generalizable use.
Use in clinical trials. The DASH or QuickDASH has been used in 35 randomized controlled 
trials of interventions for various shoulder disorders up until the end of 2015 (2). Recent 
examples include trials of open reduction internal fixation for humeral shaft fracture (230), 
exercise to prevent shoulder problems in women undergoing breast cancer treatment (231), 
and platelet-rich plasma therapy for degenerative tendinopathies (232).
Critical Appraisal of overall value to the rheumatology community 
Strengths. The DASH has been extensively tested and is widely used as a self-assessment 
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useful where measurement of symptoms and function of the entire upper extremity is 
wanted. Since shoulder function determines the position of the elbow and the hand, the 
DASH is also useful in all elbow and hand conditions. The QuickDASH total score yields very 
similar values to those of the DASH and the total scores correlate highly to each other. 
Caveats and cautions. The DASH covers the whole upper extremity and not only the 
shoulder. Its specificity and responsiveness is generally lower than shoulder-specific tools, 
although higher than generic quality of life tools. This limits its usefulness in assessing 
outcome from shoulder-specific conditions. The DASH includes items relating to the lower 
part of the limb where (dis)ability is not expected to change, and this may account for its 
poorer performance. There is evidence that the DASH score is also influenced by disability of 
the lower extremity. In addition Rasch analysis has revealed scoring issues and item misfit. 
Compared to other instruments, the strict 90% missing rule produces a relatively high 
percentage of missing data. 
Clinical usability. The DASH is a good tool for comprehensive assessment of upper extremity 
conditions, i.e., if shoulder problems cannot be differentiated from hand problems. It is easy 
to apply, analyze and interpret. Comparison of empirical and normative data allows valid 
description of the patient’s upper extremity status. The QuickDASH provides the necessary 
short assessment for clinical visits.
Research usability. The DASH is good for research purposes in various upper extremity 
conditions. It is well tested and there is a large body of data for comparison of different 
settings and different upper extremity instruments, especially for analysis of construct 
validity compared to other instruments. However concerns about its lack of specificity to 
shoulder function and its relatively limited responsiveness indicate it is not the instrument 
of choice for shoulder function.
University of California–Los Angeles (UCLA) Shoulder Rating Scale 
Description
Purpose. This multidimensional scale was originally developed to obtain information about 
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been used to assess outcome of patients with other shoulder conditions undergoing surgery 
or non-operative treatment. The original three-item version of the UCLA Shoulder Rating 
scale was published in 1981 and completed by the clinician (233). No details on method of 
development were published. A modified UCLA scale that includes both self-assessment and 
clinician-assessed items to assess outcome from rotator cuff surgery was published in 1986 
(234), and this is the version that is most widely used. A self-reported version of the 
modified UCLA scale that modified the two clinician-assessed items for self-report was 
published in 2008 (235). 
Content or domains. The original UCLA includes three domains: pain, function and muscle 
power and motion (233). The most commonly used version (234), as well as the patient-
completed version (235), includes five domains: pain, function, active forward elevation, 
strength and patient satisfaction (after surgery). Other versions include one with two 
additional domains (abduction range of motion and abduction strength)(236); inclusion of  
patient satisfaction item to the original UCLA (146); exclusion of patient satisfaction (as it 
asks about satisfaction of treatment so is not suitable as a measure of status)(237); and an 
Italian version which includes only two pain and function (25). 
Number of items. Vary between three items (original UCLA)(233) and seven items (modified 
version with addition of two new items for abduction (236). The most commonly used 
version, the modified UCLA scale, as well as the  patient-reported UCLA both have five items 
(234, 235). One version has four items (excluding the patient satisfaction item)(237) and the 
Italian version has only two items (pain and function)(25).
Response options/scale. In the original UCLA scale all items have weighted scores out of 10 
based upon categorical responses (233). Pain: Constant, unbearable;  strong medication 
frequently (1 point); Constant, but bearable; strong medication occasionally (2 points); 
None or little at rest; occurs with light activities; salicylates (4 points); With heavy or 
particular activities only; salicylates occasionally frequently (5 points); Occasional and slight 
(8 points); and No pain (10 points). Function: Unable to use arm (1 point); Very light 
activities only (2 points); Light housework or most daily living activities (4 points); Most 
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only; able to work above shoulder level (8 points); and Normal activities (10 points). Muscle 
power and motion: Ankylosis with deformity (1 point); Ankylosis with good functional 
position (2 points); Muscle power poor to fair; elevation less than 60°, internal rotation less 
than 45° (4 points);Muscle power fair to good; elevation 90°, internal rotation 90° (5 points); 
Muscle power good or normal; elevation 140°, external rotation 20° (8 points); Normal 
muscle power; motion near normal (10 points). 
In the modified version there are six similar response options for pain and function although 
the numerical weightings differ (234). Pain options are: Present always and unbearable, 
strong medication frequently (1 point); Present always but bearable, strong medication 
occasionally (2 points); None or little at rest, present during light activities, salicylates used 
frequently (4 points); Present during heavy or particular activities only, salicylates used 
occasionally (6 points); Occasional and slight (8 points); and None (10 points). Function 
options are: Unable to use limb (1 point); Only light activities possible (2 points); Able to do 
light housework or most activities of daily living (4 points); Most housework, shopping, and 
driving possible, able to do hair and to dress and undress, including fastening bra (6 points); 
Slight restriction only, able to work above shoulder level (8 points); and Normal activities (10 
points). There are also six response options for both active forward flexion and strength of 
forward flexion (manual muscle testing) and two response options for satisfaction of 
patient. The six response options for active forward flexion are 150° (5 points); 120°-150° (4 
points); 90°-120° (3 points); 45°-90° (2 points); 30°-45° (1 point); and <30° (0 points). 
Strength of forward flexion (manual muscle testing) Grade 5 (normal) (5 points); Grade 4 
(good) (4 points); Grade 3 (fair) (3 points); Grade 2 (poor) (2 points); Grade 1 (muscle 
concentration) (1 point); and Grade 0 (nothing) (0 points). Satisfaction of patient: satisfied 
and better (5 points) or not satisfied and worse (0 points). 
In the patient-reported UCLA, the response options for pain, function and satisfaction are 
the same (235). For active forward flexion the patient is asked how high they can lift their 
arm forwards, with the degrees shown pictorially. For strength of forward flexion they are 
asked how strong their arm is by comparison with the power/strength in their other arm. 
There is a picture asking them to ask someone to resist them as they lift their arm up. The 
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(4 points), fair strength – moderately weaker (3 points), poor strength – much weaker (2 
points), muscle contraction only (1 point) and nothing (0 points). In the version that added 
items measuring abduction range of motion and abduction strength the response items and 
scores (up to 5 points) are the same as the active forward flexion and strength of forward 
flexion items (236).
Recall period for items. Not specified in the original version but the current online modified 
UCLA version specifies the past 4 weeks (see below).
Cost to use. Free of charge.
How to obtain. The link for the modified UCLA scale can be downloaded for free from the 
following websites including https://www.orthopaedicscores.com and 
https://www.orthotoolkit.com/UCLA-shoulder/.
An abridged Italian version (only pain and function items) can be found in refs (25, 170) and 
a Brazilian Portugese version is published in ref (238). 
Practical application
Method of administration. In the original UCLA all three items are completed by the 
clinician (233). In the modified version, three items are completed by the patient (pain, 
function and satisfaction) and two are completed by the clinician or observer (active 
forward flexion and strength of forward flexion) (234). In the modified patient-reported 
version all items are completed by the patient (235).
Scoring. In the original 1981 version of the UCLA each of the three items is scored out of a 
maximum of 10 points (233). It was noted in this version that occasionally analysis of pain, 
function and range of motion does not fit exactly the numerical criteria indicated and the 
interval numbers provide flexibility for ‘in-between’ indications. 
In the modified UCLA scale and the patient-reported version, each of the five items 
contribute unequally to an overall score out of 35, with higher scores indicating better 
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elevation (5 points; weighting, 14.3%), strength of forward flexion (5 points; weighting, 
14.3%), and satisfaction (5 points; weighting, 14.3%)(234, 235). The reason for the weighting 
was not described in the modified version. The modified scale can also be converted into a 
100-point scale. There are no subscales.
Computer scoring is not necessary but online scoring programs are available at http:// 
www.orthopaedicscores.com; https://www.orthotoolkit.com/UCLA-shoulder/
Score interpretation. In the original UCLA scale a score greater than 8 for pain, function and 
range of motion was considered to be excellent, >6 good, 2 to 4 fair and <3 poor (233). In 
the modified and patient-reported versions of the UCLA, a score of 34 or 35 is considered 
excellent, 28 to 33 good, 21 to 27 fair, and 20 or less points is considered poor (234, 235). 
Good or excellent scores (above 27) indicate a satisfactory result while fair or poor scores 
(27 and below) indicate unsatisfactory results. One study used cut offs of 34 or 35, 29 to 33 
and <29 to indicate excellent, good and poor results respectively (239). In the 7-item version 
of the UCLA scale (range of possible scores 2 to 45), scores of 41-45 and 36 to 40 indicate 
excellent and good scores respectively (236). 
Normative data for the modified 4-item UCLA scale (leaving out the patient satisfaction 
item)(range 2-30) has been reported in 635 asymptomatic, healthy volunteers in Australia 
(N=323) and Canada (N=312)(9). People without a history of shoulder pathology reported a 
higher (better) mean UCLA score compared to those with a history of a shoulder problem 
(28.9 (range 2-30) versus 28.3, Wilcoxon rank sum test p=0.0005). No differences in scores 
were observed in people with and without a current wrist or elbow problem or handedness. 
There was no important difference between genders adjusted for nationality (women mean 
of 28 versus 29 in men, p=0.4768). Mean score declined slightly with increased age after age 
50-59. An unexplained statistically significant difference in scores overall (and by age group) 
was observed between countries with a trend for lower scores among Canadians.
Normative data for the modified 4-item UCLA scale in 120 shoulder throwing and non-
throwing college athletes and recreational athletes (aged less than 40 years or 40 years and 
older without a history of shoulder or neck pain, have also been reported (237). Across all 
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(85.7 to 100%) for recreational athletes 40 years or older to 99% (89.3 to 100%) for non-
throwing college athletes. Men were found to score higher on the active forward flexion 
subscale score (0.15 points higher out of 5 points, p =0.004). Subgroup type contributed 
significant but small effects for the pain subscale.
Respondent time to complete. Time to complete the UCLA has not been reported. However 
it is easy to understand and relatively short (5 items for the modified UCLA), and is likely 
completed within a few minutes.  
Administrative burden. All versions other than the self-reported version of the UCLA, 
require an assessor and face-to-face interaction to assess the forward flexion and strength 
of forward flexion items. Item ratings can be typed or scanned into an electronic database. 
Score computation is easy (see above). Little special training is necessary for these activities.
Translations/adaptations. There is a Brazilian-Portugese version of the modified UCLA 
Shoulder Rating Scale (238). It modified five response options for pain and four for function. 
There is also an Italian version of the pain and function items of the modified UCLA (25). 
Both translated versions included cross-culture adaptation.
Psychometric Information
Floor and ceiling effects. The presence/absence of floor and ceiling effects have not been 
reported.
Reliability. The modified UCLA has single items measuring each domain so internal 
consistency cannot be measured. However one study found that the Italian UCLA scale 
version of the pain and function items had high internal consistency with a Cronbach’s α > 
0.89, and both items correlated with the total score (r > 0.54 (25).
Good test-retest reliability of the three self-reported items in the modified UCLA has been 
reported in a mixed post shoulder surgery population (N= 31 (mostly RC tears (N=20) and 
instability (N=9)): ICCs for pain = 0.78 (95% CI 0.58 to 0.89), function = 0.89 (0.78 to 0.94) 
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reliability in a mixed group who had not undergone surgery: pain 0.59 (0.25–0.80), function 
0.51 (0.14–0.75) and satisfaction unable to be estimated. The authors suggested that the 
modified UCLA may not be appropriate for use in a non-surgical population. Another study 
however found good test-retest reliability in 20 patients who had surgical or conservative 
management at 6, 12 and 13 weeks post proximal humerus fracture (ICC: 0.93 (0.76 to 
0.97)(145). The Pearson correlation coefficient was r > 0.91 for test-retest of the Italian 
version of the pain and function items in 40 patients with damage to the spinal accessory 
nerve during neck resection for head and neck cancer causing shoulder syndrome (25). 
There was also acceptable test-retest reliability of the 2-item Italian version of the modified 
UCLA in a population of patients who had been treated with surgery for anterior shoulder 
instability (r= 0.93 for UCLA pain subscale, 0.95 for UCLA function subscale (170).
Validity. One study in patients undergoing rehabilitation post-proximal humerus fracture 
assessed content validity of the modified UCLA score linked to ICF codes (145). Apart from 
subjective shoulder value (‘‘not definable’’), items linked with two ICF components: 
“(b)Body Functions” (pain, joint mobility, muscle strength/endurance) and “(d)Activities and 
participation” (using transport/driving, self-care, dressing, shopping, housework). All items 
linked with body functions were separate items while all items in activities and participation 
were combined within a single item. 
Pearson’s or Spearman’s correlations of the modified UCLA Shoulder Rating scale to other 
instruments, and the population measured in, are as follows:
ASES: Arthroscopic rotator cuff population, pre-surgery, 6, 12 and 24 months post-surgery: 
very high correlation overall (r =  0.91), moderate in the preoperative period (r =  0.67, high 
at 6 months after surgery (r =  0.87) and very high at 12 and 24 months (r =  0.90 and 0.92) 
(73); mixed population with rotator cuff disease, isolated superior labral anterior posterior 
(SLAP) lesions, and shoulder instability after surgery 0.38 (69).
WORC: Mixed population of Brazilian patients with rotator cuff disorders: r = 0.80)(240). 
WOSI: Patients having treatment for instability: r = 0.649 at baseline (prior to intervention) 
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OSS: Proximal humerus fracture: r = 0.77 (at 6 weeks), 0.83 (at 12 weeks), 0.73 (for change 
scores from 12 to 13 weeks (145); impingement or calcific tendinitis in German patients: r = 
0.66 (187); Italian patients after shoulder surgery for anterior instability: r = 0.67)(185)
DASH: Proximal humerus fracture: r = 0.65 (at 6 weeks), 0.84 (at 12 weeks), -0.65 (for 
change scores from 12 to 13 weeks (145).
 SSV: Proximal humerus fracture: r =  0.45 (at 6 weeks), 0.81 (at 12 weeks), 0.46 (for change 
scores from 12 to 13 weeks (145).
CM: Proximal humerus fracture: r =  0.70 (at 6 weeks), 0.92 (at 12 weeks), 0.83 (for change 
scores from 12 to 13 weeks (145).
One study assessed correlation of the modified UCLA with other shoulder measures in 
people without shoulder complaints: ASES: r = 0.65; CM Shoulder Score: r = 0.42; OSS: r = 
0.80; Shoulder Pain and Disability Index (SPADI) r = -0.68; and Stanmore Percentage of 
Normal Shoulder Assessment (SPONSA): r = -0.63 (9). Correlation of the 4-item UCLA has 
been reported in patients with previous rotator cuff repair: SST: r = 0.76; CM: r = 0.66 (146). 
The UCLA scores were higher than the CM scores in almost all participants, while correlation 
with forward motion and the abduction ratio was only 0.37 (poor) and 0.48 (fair) 
respectively. 
Correlations of the modified UCLA function subscale score in a mixed shoulder population, 
46% of whom were post-surgery were: SPADI disability subscale: r = 0.64; SST: r = 0.60 (29). 
Correlations with the UCLA pain subscale score were: SPADI pain subscale: r = 0.63, while 
discriminant validity of the modified UCLA pain and disability subscales was r=-0.64 
indicating greater convergence than divergence between these subscales. In a study 
including patients after shoulder surgery for anterior instability, correlations of the Italian 
version of the pain item of the modified UCLA scale were: SPADI: total SPADI r = -0.63, 
SPADI pain subscale r = -0.61, SPADI function subscale r =  -0.64 subscales and SST: r = 0.61; 
while correlations with the function item were: SPADI: total SPADI r = -0.57, SPADI pain 
subscale r = -0.52, SPADI function subscale r =  -0.60 subscales and SST: r = 0.51) (170). 
Agreement between the modified UCLA and patient-reported UCLA. Acceptable agreement 
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decompression or rotator cuff repair, N=100): ICC = 0.910 (95% confidence interval (CI), 0.87 
to 0.94) for whole cohort; ICC = 0.951 (95% CI, 0.92 to 0.97) for cohort who had subacromial 
decompression (N=46); and ICC = 0.734 (95% CI 0.61 to 0.83) for cohort who had rotator 
cuff repair (N=54)(235). Patient-derived scores were slightly lower (worse outcomes) in the 
order of one point compared with two clinician assessors, mostly explained by differences in 
the strength of forward flexion item. This could have arisen due to patient apprehension in 
pushing against resistance when performing self-assessment compared with being more 
confident when this was performed in the presence of the clinician and/or greater clinician 
encouragement to push against resistance despite any pain. 
Responsiveness. Reported effect sizes (ES) and standardized response means (SRMs) of the 
modified UCLA according to patient population are as follows: subacromial decompression: 
ES at 6 weeks, 6 and 12 months: 1.17, 2.0 and 2.73 points; SRM at 6 weeks, 6 and 12 
months: 0.83, 1.41 and 1.69 points (241); surgery for instability: SRM 0.385 points (147); 
rotator cuff disorders three months after treatment (surgery or physiotherapy)(Brazilian 
Portugese version): ES 1.17; SRM 1.66 points (242); 
Minimally important differences. In patients being treated for proximal humerus fractures 
MCID for improvement was found to be 2.4 points from an anchor-based method (mean 
score of five patients who reported a small overall improvement was used to anchor the 
MCID for improvement) and 2.0 points from a statistical distribution-based method (145). 
No patients deteriorated so no MCID for deterioration was reported. 
The MDC of the Italian version of the UCLA was found to be 0.90 (1.77) for pain and 0.15 
(0.30) for function (170).
Generalizability. The UCLA and later versions has been predominantly used to assess 
outcome from various surgical procedures (shoulder arthroplasty, arthroscopic subacromial 
decompression, open and arthroscopic rotator cuff repair and surgery for anterior 
instability) but has also been used to assess proximal humerus fractures and shoulder 
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Use in clinical trials. Up to December 2015, the modified UCLA or other versions has been 
used in 35 randomised controlled trials (2). Examples from the last five years include 
therapeutic ultrasound (243), mirror therapy (244), platelet-rich plasma injection (245) for 
adhesive capsulitis; deep heat versus ultrasound for shoulder pain (46); immediate versus 
delayed passive mobilization (246, 247) doxycycline (248) and platelet rich plasma (249) 
following rotator cuff repair; double versus single row rotator cuff repair (250, 251), suture-
spanning augmentation of single-row rotator cuff repair (117); rotator cuff repair with or 
without acromioplasty (87); acupuncture (252), kinesiotaping and subacromial 
corticosteroid injection (253), ultrasound-guided subacromial NSAID or glucocorticoid 
injection (254) for impingement syndrome and open versus arthroscopic repair of traumatic 
anterior shoulder instability (255). Only one older trial to date, which assessed the efficacy 
of ropivacaine infusion versus placebo following rotator cuff surgery, has used the patient 
self-reported version of the UCLA scale (256).
In many trials conducted in countries where English is not the first language it is unclear 
whether or not the UCLA was cross culturally translated into the local language e.g., trials 
conducted in Korea (46), Turkey (244, 253), China (245, 247, 254), Belgium (246), Mexico 
(248), Italy (250). Taiwan (117), Brazil (249), Spain (252) and Japan (251, 255). One ongoing 
trial comparing figure-of-eight bandage versus arm sling for treating middle-third clavicle 
fractures in adults is using the Brazilian Portugese version of the modified UCLA scale (257). 
Critical Appraisal of overall value to the rheumatology community 
Strengths. The psychometric properties of the UCLA scale and its modified versions have 
been tested across many non-inflammatory shoulder disorders in surgical and non-surgical 
populations. Normative data are available and the UCLA scale score does not appear to be 
influenced by gender or handedness but scores do decline slightly with age. A self-
administered version, which performs acceptably compared to when an observer assesses 
forward flexion and strength of forward flexion, is available and may be useful in situations 
where face-to-face assessment is not possible or desirable. The modified UCLA scale 
appears to have good test-retest reliability and has moderate to good construct validity in 
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but the MID has only been reported for people following proximal humeral fractures. 
Caveats and cautions. The modified UCLA is a multidimensional tool with only single items 
measuring pain, function, forward flexion and strength of forward flexion. An additional 
item, patient satisfaction, can only be applied following treatment. A major issue with many 
of the item responses for pain are that they combine frequency and severity of pain and the 
type and amount of medication required to relieve the pain within single response options 
which may make it difficult to choose an appropriate response. This problem also affects 
some of the response options for function which combine multiple functional activities 
within the single option. The validity of the weightings of responses within the pain and 
function items has not been evaluated. The satisfaction item is also problematic: only two 
response options are possible (satisfied and better or not satisfied and worse) so it is 
unclear how to respond if the respondent considers themselves unchanged. In addition this 
item implies an intervention has taken place and this item could not be administered before 
an intervention. Finally a patient might be unchanged or worse but be satisfied, or they 
might be better but still not be satisfied.  
Combining multiple domains into a single total score means that the score cannot inform 
specifically about the pain or function or other constructs a patient experiences. Multiple-
item scales also yield much more reliable measurements than do single-item scales. It is 
doubtful therefore that the UCLA is precise enough to effectively follow the progress of 
individual patients in the clinic setting (29). Floor and ceiling effects have not been reported.
Clinical usability. Combination of self and clinical assessment and solely self-assessment 
versions are available. Widely used to assess outcomes from shoulder surgery and non-
operative treatments across a range of conditions. Further assessment of its measurement 
properties is still needed and caution is necessary when interpreting the total score which 
combines single items across several domains. 
Research usability. Use with caution because of its many identified caveats. Further testing 
is needed to fully understand its psychometric properties for various patient groups. Cross-
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are needed and should be used for studies for trials and other research conducted in 
languages other than English. The patient self-assessment version of the UCLA might be 
preferred when face-to-face assessment is not possible or desirable. 
Western Ontario Rotator Cuff (WORC) Index
Description
Purpose. The original version of the WORC Index was published in 2003 and developed to 
specifically measure disorders of the rotator cuff (258). It has also been used and evaluated 
for patients with rotator cuff repair (259), shoulder instability (260) and winged scapula 
(261).
Content or domains. There are five domains: physical symptoms, sports/recreation, work, 
lifestyles and emotions (258). 
Number of items. There are 21 items in total: 6 in Physical symptoms, 4 in 
Sports/recreation, 4 in Work, 4 in Lifestyles, and 3 in Emotions (258).
Response options/scale. All items are rated using a visual analogue scale (VAS) (258). On 
the paper version the lines are 100 millimeters long.
Recall period for items. Two weeks.
Cost to use. Free of charge. 
How to obtain. Available in various references, e.g., (258).
Practical application
Method of administration. Self-assessment using pen and paper (258) but it has also been 
delivered electronically in many studies. 
Scoring. Each item is scored from 0 (best) to 100 (worst). The total score ranges from 0 to 
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indicating better function.
Score interpretation. A higher score indicates poorer function but on the percentage scale a 
higher percentage indicates better function. There are no cutoff points to indicate severity. 
One study reported that pretreatment, the average WORC score among patients with 
rotator cuff repair, disorders of the rotator cuff and shoulder instability was 37.8, 48, and 
55.7 respectively (260), and it increase to 78.8, 737.7, and 89.8 six months after treatment 
among patients in the three groups, respectively. Another study recruiting a mixture of 
patients with impingement syndrome or rotator cuff pathology reported that the WORC 
score increased from 39.85 before treatment to 70.15 six months after treatment (149).
Respondent time to complete. Mean time to complete the WORC Index is 3 minutes. 
Administrative burden. Scoring is straightforward and no special software or equipment is 
required (260). VAS is less favored by some patients and may take more time to record 
scores. 
Translations/adaptations. The WORC Index has been translated into multiple languages. 
Cross-cultural validation has been performed for the following languages: Chinese (262), 
Swedish (263), Canadian French (264), Polish (265), Turkish (266), Brazilian Portuguese 
(267), Persian (268) (269) and Norwegian (15, 270).
Psychometric information
Floor and ceiling effects. The floor and ceiling effects of the WORC Index overall score was 
1.1% and 5.6% respectively in a study of patients with rotator cuff disease and shoulder 
instability (260). They were low across all domains except for floor effects for the Work 
domain (12.2%) and ceiling effects for the Emotions domain (14.4%). A substantial ceiling 
effect (39.1%) of the WORC Index overall score was observed six months after treatment 
when patients had improved and this was evident across all domains (ranging from 34.5 to 
56.3%) except for the Shoulder Hindrance score (0%).
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ranging from 0.54 (Work domain) to 0.91 (Physical Symptoms), and 0.96  for the total score 
(258).
Validity. The convergent validity of the WORC is relatively good. The Pearson correlation 
coefficient between the WORC and the absolute CM, relative CM (age-adjusted), and the 
ASES was r = 0.65, 0.66, and 0.73, respectively in patients with impingement or rotator cuff 
pathology, a third of whom fulfilled criteria for surgery (149). In another study, the 
correlation between the WORC and the Physical Summary Score of the SF-36, SST and DASH 
was  r= 0.58, 0.91, and 0.88, respectively in patients following rotator cuff repair (271). 
However, lower correlations were reported between the WORC and the ASES, UCLA and 
DASH in another study of patients with rotator cuff disease receiving various treatments (r = 
0.68, 0.48, and 0.63, respectively (258).
The longitudinal convergent validity has been reported to be relatively high. In one study 
that measured change in patients with impingement or rotator cuff pathology, a third of 
whom fulfilled criteria for surgery, at six months after treatment, the correlation between 
the change in the WORC and the change in the absolute and relative (age-adjusted) CM and 
ASES was r = 0.77, 0.70, and 0.85, respectively  (149). Another study in patients with rotator 
cuff disease receiving various treatments the reported correlations of the change in scores 
between the WORC and the ASES, UCLA and DASH of r = 0.76, 0.72, and 0.66  respectively 
(258)..
The discriminant validity of the WORC is satisfactory, as shown by correlations with 
objective measurements. For example, the correlation between the WORC and external and 
internal rotation strength and external and internal rotation range of motion was r = 0.38, 
0.45, 0.27, and 0.31, respectively in patients following rotator cuff repair (271). The WORC 
also has been reported to have low correlations with subscales of the SF-36 (r < 0.5) except 
for Physical function (r = 0.56) in patients with rotator cuff disease (258). Another study 
reported correlations for the WORC and the strength of the affected arm as well as the 
unaffected arm as r = 0.42 and 0.1, respectively in patients with impingement or rotator cuff 
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The longitudinal discriminant validity of the WORC is also satisfactory, as shown by the low 
correlations between the change of the WORC and the change of all subscales of the SF-36 
(r < 0.5) except for Role Physical (r = 0.52) when evaluated 3 months after various 
treatments for rotator cuff disease (258). The correlations between the change in WORC 
and change of strength of the affected and unaffected arms was r = 0.37 and 0.20, 
respectively, when evaluated 6 months after various treatment in patients with rotator cuff 
disease in another study (149).
The WORC has good known group validity. For example, the WORC can differentiate 
between patients whose occupation is affected by shoulder symptoms and the ones who 
are not (149). The WORC can also detect the difference between patients whose range of 
motion in external rotation is >45o and the ones whose range of motion is <45o, and 
between  patients receiving or not receiving workers’ compensation (271). The longitudinal 
known group validity of the WORC was questioned in one study on the basis that it failed to 
detect change in patients with less compared with more pathology as determined by the 
requirement for more extensive surgery at three and six months after treatment (149).
Responsiveness. As a specialized instrument, the WORC has good responsiveness. The 
correlation between the WORC change score and the shoulder hindrance score is r = 0.51, 
0.55, and 0.43 among patients with rotator cuff repair, disorders of the rotator cuff without 
rupture, and shoulder instability, respectively (260). In another study, an ANOVA showed 
the WORC score can differentiate between change from baseline, 3 and 6 months after 
rotator cuff surgery treatment with an SRM = 1.33 (149).
Minimally important differences. The MDC of the WORC among patients with rotator cuff 
repair, disorders of the rotator cuff without rupture, and shoulder instability in one study 
was 16.7%, 20.3%, and 25.4%, respectively (260). In the same study the MIC of the WORC 
estimated by ROC cut-off was 34%, 22.9%, and 31.8%, respectively, while the MIC estimated 
by 95% limit cut-off was 35.3%, 41.9%, and 46%, respectively.
Generalizability. The WORC is a rotator-cuff specific measurement instrument that has 
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instability. It has also been shown to have moderate validity among patients with winged 
scapula (261).
Critical appraisal of overall value to the rheumatology community
Strengths. The WORC is relatively short, easy to administer and score, has good overall 
evidence for construct validity and responsiveness. It is readily obtained at no cost, and 
cross-cultural validation has been performed for multiple languages.
Caveats and cautions. More studies are needed to evaluate measurement error, 
interpretability (272) and reliability in patients with rotator cuff disorders. The 
responsiveness of the WORC has been questioned for some other languages (27, 273).
Clinical usability. Useful in a clinical context for assessing rotator cuff disorders. Relatively 
brief, easy to administer and score, and responsive to change.  
Research usability. The WORC Index is brief, easy to administer and responsive and is valid 
for assessing various treatment in many settings. It is available for use in multiple languages. 
Patient-Reported Outcomes Measurement Information System (PROMIS) Physical 
Function Upper Extremity Computerized Adaptive Test (CAT)
Description
Purpose.  PROMIS Physical Function Upper Extremity CAT measures upper extremity 
function (274). It was originally developed in 2014 as part of the PROMIS initiative which is 
an NIH Common Fund project involving the dynamic assessment of patient-reported 
outcomes. PROMIS includes item banks that measure key health symptoms/concepts for 
both the general population and several chronic conditions. PROMIS item banks assess 
physical (physical function, fatigue, sleep disturbance, sleep related impairment, pain 
behavior, and pain interference), emotional (depression, anxiety, and anger), cognitive 
(applied cognition-abilities and applied cognition general concerns), and social (ability to 
participate, satisfaction with social roles and activities, emotional support, instrumental 
support, informational support, and social isolation) health. These item banks were 
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statistical analysis (275-279). This included state-of the art psychometric analysis including 
classical test theory approaches and item response theory. Items can be administered as a 
full set, a computerized adaptive test (CAT), or a calibrated “short form” (preselected set of 
items). An item bank that can be administered as a CAT provides an advantage to any 
preselected set of items (i.e., short form) in maximizing assessment sensitivity while 
simultaneously minimizing the number of items needed. 
Content or domains. Upper extremity physical function.
Number of items. There is a maximum of 12 of the 16 items when using the CAT.  The CAT 
presents a maximum of 12 questions in a dynamic order, with the exact question 
determined by the response to a prior question. The questionnaire is considered completed 
when the expected change in the score with additional questions drops below a specific 
threshold. 
Response options/scale. Response options range from 1 to 5 (1 unable to do, 2 with much 
difficulty, 3 with some difficulty, 4 with a little difficulty and 5 without any difficulty).
Recall period for items. All items are phrased in the present tense. 
Cost of use.  Free of charge. 
How to obtain. Free versions are available online at 
http://www.healthmeasures.net/explore-measurement-systems/promis
Practical application
Method of administration. Self-assessment, either using pen and paper for the static 
version, or electronically for the CAT version.
Scoring. The questionnaire is considered completed when the expected change in the score 
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using a t metric, with a mean of 50 and standard deviation of 10; higher scores indicate 
more of the construct (e.g., higher scores indicate greater function).
Score interpretation. This approach allows for estimation of an individual’s functioning 
relevant to the reference group (which, for PROMIS, is the general population). For 
example, scores of 60 or greater on a PROMIS measure indicate that the individual has more 
of a specific trait (e.g., physical function of the upper extremity) than 68.27% of people in 
the general population. Scores above 70 indicate that self-reported physical function 
exceeds 95.45% of people in the general population. These scores can be used as referents 
for making appropriate clinical comparisons.
Respondent time to complete. Takes approximately 70 seconds to complete (range 25 to 
307 seconds) according to one study (280), 61.3 seconds on average (sd=28.8) in another 
study (281), and 96.9 seconds (sd=25.1) in a third study (282). As completion of the CAT 
depends on the exact responses to each item, this dictates the total number of items that 
are completed and the time involved. 
Administrative burden. The PROMIS instruments can be scored on the Assessment Center 
web-based platform or by other electronic data collection methods (e.g., RedCap) that have 
access to scoring algorithms for arriving at t-scores. The Assessment Center (AC) enables the 
investigator to create a data collection website including any PROMIS item banks and short 
forms (283). It supports data collection designs that include multiple time points and 
multiple treatment arms and enables investigators to monitor enrollment of participants 
and completeness of data collection during the course of their research.
Translations/adaptations. It has been translated into Dutch-Flemish (284).
Psychometric information
Floor and ceiling effects. No floor or ceiling effects have been found in studies including 
patients with hand or upper extremity conditions (280), shoulder arthritis (282), shoulder 
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varying types of rotator cuff disease(286), and patients with upper extremity fractures 
(287).  
A study including patients who underwent operative treatments for shoulder instability 
reported ceiling effects at 6 months (68.1%) and 2 years (67.0%) (288). In a subgroup aged < 
21 years ceiling effects were 71.1% at 6 months and 81% at 2 years. Ceiling effects were 
found for 3% patients (t-score of 56 or higher) undergoing arthroscopic rotator cuff repair 
(289), and 7.2% (t-score of 56 or higher) of patients with hand or shoulder conditions (290). 
The latter study also reported 1.2% floor effects. Another study showed ceiling effects in 
11.4% of patients with shoulder instability with varying ceiling effects for different age 
groups (291). A further study showed ceiling effects when inspecting item loadings on lower 
functional ability levels (292). A study in upper extremity trauma patients found no floor 
effects but ceiling effects in 5.2% (at a mean of 13 weeks post surgery) and 18.2% (at a 
mean of 37.9 weeks post surgery)(293). 
In a systematic review of floor and ceiling effects across 12 studies including 18,113 
patients, Gulledge et al reported floor effects ranging from 0-1.6% and ceiling effects 
ranging from 0-28% (294).
Reliability. There is some evidence of person and item reliability in patients with shoulder 
instability: item reliability r = 0.82 to 0.96, person reliability r = 0.84 to 0.85 (291, 292). In 
patients with upper extremity trauma the average marginal reliability was r = 0.90 (293).
Validity. A Rasch analysis of 1,197 adults patients with varying hand and upper extremity 
complaints (non-shoulder) showed the item bank fit a unidimensional model (Eigen value of 
1.96) with 4.2% unexplained variance (292). There was also no differential item functioning 
local independence of items (r=-0.37 to 0.34) and item fit was also adequate in the Rasch 
model. In another study of 734 patients with isolated shoulder, elbow or wrist fractures a 
factor analysis revealed the PROMIS physical function upper extremity to load onto one 
factor only reflecting capability which was separate from another factor reflecting quality of 















This article is protected by copyright. All rights reserved
There is evidence for low to high correlations between the PROMIS Physical Function Upper 
Extremity and various generic quality of life measures, measures of psychological function, 
upper extremity measures, general measures of physical function, pain, shoulder-specific 
measures and rotator cuff measures. These associations have been reported in a variety of 
settings (e.g, academic medical centers, outpatient clinics) and in patients with a variety of 
shoulder conditions such as humeral fractures, rotator cuff muscle and tendon tears, 
adhesive capsulitis, bursitis, tendonitis, impingement, instability, and in some cases in mixed 
sample of hand, elbow or shoulder conditions. Pearson’s or Spearman’s correlations or 
other relevant statistics of the PROMIS Physical Function Upper Extremity CAT to other 
instruments, and the population measured in, are as follows:
Short Musculoskeletal functional assessment (SMFA): Upper extremity trauma: r= -0.76 to -
0.69 (293)
Quick-DASH: Upper extremity trauma: r= -0.82 to -0.75 (293); hand and upper extremity 
conditions: r=-0.81 (280); upper extremity fractures: r=-0.47 to -0.83 (1 week, 9 
months)(287)
PROMIS Physical Function- Short Form 8a (PROMIS-PF-SF8a): Upper extremity trauma: r= 
0.73 to 0.77 (293)
PROMIS Physical Function CAT (PROMIS PF CAT): Shoulder instability: r=0.63 (291); Rotator 
cuff pathology: r=0.70 (286); Upper extremity conditions: r=0.69 (baseline), r=0.53 
(change)(290); hand and upper extremity conditions: r=0.48 (280)
PROMIS Pain Interference CAT (PROMIS PI): hand and upper extremity conditions: r=-0.60 
(280)
PROMIS Mobility CAT (PROMIS M): hand and upper extremity conditions: r=0.41 (280); 
pediatric and adolescent patients in a ambulatory sports medicine clinic: r=-0.75 (295)
PROMIS Depression CAT (PROMIS D): arthroscopic rotator cuff repair patients: r2=-0.196 
(preoperative), r2=-0.431 (postoperative)(296); pediatric and adolescent patients in a 
ambulatory sports medicine clinic: r=-0.21 (295)
ASES: Shoulder instability: r=0.71 (291); rotator cuff pathology: r=0.77 (286); total shoulder 
arthroplasty: r=0.55 (285); shoulder pain (across conditions): r=0.72 (281); adhesive 
capsulitis: r=0.86 (281); failed arthroplasty: r=0.49 (281); fracture: 0.87 (281); instability: 
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other shoulder pain: r=0.74 (281); shoulder arthritis: r=0.57 (282); rotator cuff repair: r=0.59 
(289).
WOSI: Shoulder instability: r=0.63 (291); 
Marx Shoulder Activity Scale (Marx): Shoulder instability: r=0.06 (291); rotator cuff 
pathology: r=0.23 (286); total shoulder arthroplasty: r=0.06 (285).
Short Form 36-Health Survey Physical Function Subscale: Shoulder instability: r=0.78 (291).
SF36: Rotator cuff pathology: r=0.66 (286); total shoulder arthroplasty: r=0.53 (285).
Short Form 36-Health Survey General Health (SF36 GH): Rotator cuff pathology: r=0.30 
(286).
EuroQual 5 dimensions questionnaire (EQ-5D): Shoulder instability: r=0.66 (291); Rotator 
cuff pathology: r=0.73 (286); total shoulder arthroplasty: r=0.48 (285).
 WORC: Rotator cuff pathology: r=0.73 (286).
Western Ontario Osteoarthritis Shoulder index (WOOS): total shoulder arthroplasty: r=0.34 
(285).
SST: shoulder pain (across conditions): r=0.82 (281); adhesive capsulitis: r=0.91 (281); failed 
arthroplasty: r=0.19 (281); fracture: r=0.93 (281); instability: r=0.81(281); impingement 
syndrome: r=0.93 (281); rotator cuff disease: r=0.78 (281); other shoulder pain: r=0.75 
(281); shoulder arthritis: r=0.64 (282); rotator cuff repair: r=0.62 (289).
The 2-item Patient Health Questionnaire (PHQ-2): hand and upper extremity conditions: r=-
0.30 (280).
The 2-item Pain Self-Efficacy Questionnaire (PSEQ-2): hand and upper extremity conditions: 
r=0.47 (280)
Pain (Numerical rating scale; NRS): hand and upper extremity conditions: r=-0.59 (280)
Responsiveness. Several studies report good responsiveness with the SRM, responsiveness 
to change, effect sizes in a variety of shoulder conditions. In patients with upper extremity 
trauma one study reported good responsiveness to treatment of the injury (293). This study 
also reports that effect sizes and SRM were large for the measure for the full sample, a 
subsample split by occurrence/nonoccurrence of a secondary treatment and for subsample 
split by fracture severity, although actual values are not reported in the published paper or 
in supplemental material. In another study of patients with upper extremity conditions 
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as mean = 6.1 (SD=5.8) which was comparable to an absolute mean difference of 0.80 (290). 
It also reported no differences in magnitude of change in those with hand versus shoulder 
or elbow conditions. In patients undergoing arthroscopic rotator cuff repair scores on the 
instrument were responsive to surgery with scores improving by over 10 points at 6 months 
follow-up (296). In patients with shoulder instability the instrument detected improvement 
at 6 months postoperatively with medium to large effects sizes (Cohen's d=1.09) with a 
corresponding SRM =0.92 (288). 
Minimally important differences. The minimally important difference was reported as 2.1 
in one study of patients with non-shoulder upper extremity conditions (297). 
Generalizability. This PROMIS instrument has been used in samples with various shoulder 
disorders including general shoulder pain, upper extremity trauma including fractures, 
rotator cuff disorders, instability and shoulder arthritis before and after shoulder 
arthroplasty.
Use in clinical trials. All of the studies that have explored the measurement properties of 
this instrument were cohort studies. We could find no randomized clinical trials using the 
PROMIS physical function upper extremity CAT. 
Critical appraisal of overall value to the rheumatology community
Strengths. The PROMIS physical function upper extremity CAT is short, uses item response 
theory and has very good evidence of validity, good evidence for responsiveness, has been 
used in varying shoulder conditions, and is free to use. 
Caveats and cautions.  The instrument appears to have serious ceiling effects and there is 
only minimal evidence for reliability. Furthermore, many of the studies included above 
include mixed sample of patients with varying "upper extremity" disorders and almost all 
studies do not delineate shoulder from elbow or hand disorders in any subgroup analyses. 
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Clinical usability. May be useful in a selection of shoulder related disorders. Brief, easy to 
use and score, and appears to be valid and responsive. 
Research usability. Brief, easy to administer and responsive. Valid for intervention and 
population-level studies.
Summary / recommendations
We reviewed nine of the at least 50 instruments that have been developed to measure 
adult shoulder function. Since the last review of some of these shoulder measures was 
published in a special issue of this journal in 2011 (3), there has been an enormous body of 
research evaluating their psychometric properties in patients with varying shoulder 
disorders and in different settings. Many tools have also been cross-culturally translated 
into multiple languages. Most have also been used in randomized controlled trials. This 
extensive review provides researchers with the necessary information for the eight most 
commonly used instruments in trials in the last five years as well as information for the 
PROMIS Physical Function Upper Extremity CAT.
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